Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1050.Time spend outdoors in summer,49766,0.00375197237452204,0.0357882143386905,-0.0663929277293113,0.0738968724783554,0.916505211045911
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1060.Time spent outdoors in winter,47694,-0.0424989249632547,0.0395475273778908,-0.120012078623921,0.0350142286974114,0.282554820487515
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1070.Time spent watching television (TV),50931,0.103613829423205,0.0364633577157664,0.0321456483003029,0.175082010546107,0.00449312655745797
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1080.Time spent using computer,47727,-0.096003895387878,0.0353837032580768,-0.165355953773709,-0.0266518370020475,0.00666937047036932
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1090.Time spent driving,43622,0.0394928468888749,0.0408689609139027,-0.0406103165023744,0.119596010280124,0.333895963737224
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1160.Sleep duration,51712,-0.00245591419175439,0.031858122011675,-0.0648978333346375,0.0599860049511287,0.938553343113972
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35478,-0.0174116340754666,0.0163570622442031,-0.0494714760741046,0.0146482079231715,0.28715585098971
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35478,0.00690716791528382,0.0156714182791995,-0.0238088119119472,0.0376231477425148,0.659409603880714
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35478,0.008450374942199,0.0171361484451901,-0.0251364760103736,0.0420372258947716,0.621936891695978
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35478,0.00985181747621276,0.0172781055583269,-0.0240132694181079,0.0437169043705334,0.568568654865419
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35478,0.00510737680297899,0.0172875840098642,-0.0287762878563548,0.0389910414623128,0.767670502480325
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35478,-0.0160629440409548,0.0432478713482571,-0.100828771883539,0.0687028838016291,0.710340358372444
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35478,0.0108671822776952,0.0465229081782747,-0.0803177177517232,0.102052082307114,0.815312633551851
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35478,0.0197380816583468,0.0296947746029871,-0.0384636765635079,0.0779398398802015,0.506267539185905
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35478,-0.0158632820385282,0.0214244320395871,-0.057855168836119,0.0261286047590626,0.45906707243498
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35478,-0.00153177481721969,0.0140395150368101,-0.0290492242893674,0.025985674654928,0.913123058339519
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35478,0.00458628211991932,0.0211919681331368,-0.0369499754210289,0.0461225396608675,0.828670478267862
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35478,-0.02144141186418,0.0112970835827533,-0.0435836956863764,0.000700871958016418,0.0577471444293631
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35478,-0.00770299047572748,0.0148685289978147,-0.0368453073114444,0.0214393263599894,0.604425245516633
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35478,-0.0212606535058802,0.0212049380267113,-0.0628223320382343,0.0203010250264738,0.31607923883442
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35478,-0.0213319943034638,0.020009603421591,-0.0605508170097821,0.0178868284028546,0.28642490673172
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35478,-0.0122124783457851,0.0312649647202147,-0.0734918091974058,0.0490668525058357,0.696097107301187
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35478,-0.0156602917738592,0.0293701651887896,-0.0732258155438867,0.0419052319961684,0.593911177106601
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35478,-0.0108504365030483,0.0153919906547851,-0.0410187381864271,0.0193178651803306,0.480873435076774
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35478,-0.0160105011623063,0.0145752310162176,-0.0445779539540927,0.0125569516294802,0.272039983858659
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35478,0.0023175678242891,0.0184894163464936,-0.0339216882148384,0.0385568238634166,0.900253926955276
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120040.Fatigue severity over the past week,35481,0.048255156724519,0.06240983199579,-0.0740681139872294,0.170578427436267,0.439434292910076
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35479,-0.0188329989520239,0.0625204424360208,-0.141373066126625,0.103707068222577,0.763249496869899
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35481,0.0835446696299367,0.0662190280576806,-0.0462446253631173,0.213333964622991,0.207124660202166
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120098.Mobility problems today,35485,-0.0100508799121396,0.0678580989723239,-0.143052753897894,0.122950994073615,0.882255858666213
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120099.Self-care problems today,35485,-0.157104883428595,0.104410874084628,-0.361750196634465,0.0475404297772762,0.132456766524372
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120100.Problems doing usual activities,35485,-0.112709345196944,0.0664321660665027,-0.242916390687289,0.017497700293401,0.0898202882346383
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120101.Pain or discomfort today,35485,-0.0658929557197901,0.0624645218285648,-0.188323418503777,0.0565375070641969,0.291517950509162
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120102.Anxiety or depression today,35485,-0.0116219454180914,0.078575706684559,-0.165630330519827,0.142386439683644,0.882420420344704
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120103.Scale to indicate how health is today,35463,0.00101226437815613,0.00492328987941527,-0.0086373837854978,0.0106619125418101,0.837104344568835
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35461,-0.0128870801786426,0.0804026766660385,-0.170476326444078,0.144702166086793,0.872664316905778
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35451,-0.0121987207590885,0.0836163373784815,-0.176086742020912,0.151689300502735,0.884013556724062
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35466,0.0312275957041273,0.0625979313607522,-0.091464349762947,0.153919541171202,0.617895609526823
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35465,-0.019383452473823,0.0638933624146681,-0.144614442806572,0.105847537858926,0.761616504243433
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35477,0.0740352181143492,0.0920009428306614,-0.106286629833747,0.254357066062446,0.421010357701726
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35457,0.0331205564634015,0.0902040224042711,-0.14367932744897,0.209920440375773,0.713501767452094
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35470,-0.0233950977174916,0.0892365752266431,-0.198298785161712,0.151508589726729,0.793199465173869
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35469,-0.0966661543076829,0.12307937119216,-0.337901721844315,0.14456941322895,0.4322505707323
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35448,-0.190786330476104,0.187748312191714,-0.558773022371863,0.177200361419654,0.30958236551028
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33360,-0.0877291170757854,0.0874445732576624,-0.259120480660804,0.0836622465092329,0.315796624472877
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49944,0.146375343375197,0.0777441905413838,-0.00600327008591531,0.298753956836309,0.0597439290233415
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48193,0.0574983689759631,0.0483718332596823,-0.0373104242130143,0.152307162164941,0.234582602108955
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1289.Cooked vegetable intake,51273,-0.193365009705029,0.0338478680046407,-0.259706830994125,-0.127023188415933,1.12582760220449e-08
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50492,-0.172465871385138,0.0351458664846454,-0.241351769695043,-0.103579973075233,9.30940581941788e-07
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1309.Fresh fruit intake,51196,-0.173146510873095,0.034526045455745,-0.240817559966356,-0.105475461779835,5.34587163589154e-07
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1319.Dried fruit intake,50020,-0.173722108753374,0.0347085039532644,-0.241750776501772,-0.105693441004975,5.6266575078218e-07
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X134.Number of self-reported cancers,51917,0.026414294374579,0.0538743958284053,-0.0791795214490953,0.132008110198253,0.623930589069153
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51918,-0.0598655828215308,0.0346828557221401,-0.127843980036925,0.00811281439386381,0.0843455815829229
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X136.Number of operations, self-reported",51918,-0.0659605180760371,0.0335387734611181,-0.131696514059829,-0.000224522092245619,0.0492306030713537
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X137.Number of treatments or medications taken,51918,-0.113322244716582,0.0331587246121219,-0.178313344956341,-0.048331144476823,0.000632936937386297
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1438.Bread intake,51309,0.00168358397926292,0.00279484597037504,-0.00379431412267216,0.00716148208119799,0.546921523333341
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1458.Cereal intake,50966,-0.0706901974950461,0.0329298184315782,-0.135232641620939,-0.00614775336915289,0.0318287763428916
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1488.Tea intake,51230,-0.00553983716446712,0.00270570987276894,-0.0108430285150942,-0.000236645813839999,0.0406246107100438
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1498.Coffee intake,50254,0.00293246946412494,0.0332277873350203,-0.0621939937125148,0.0680589326407647,0.929676013124124
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1528.Water intake,50085,-0.137236643159051,0.0334416432338324,-0.202782263897362,-0.0716910224207393,4.08022813721463e-05
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1568.Average weekly red wine intake,44697,-0.133290123066892,0.0388733132021715,-0.209481816943148,-0.0570984291906357,0.000607757749857511
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,44697,-0.0287421110428533,0.039521559695532,-0.106204368046096,0.0487201459603895,0.467082924571375
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,44743,0.101059372990972,0.0443166865524844,0.0141986673481028,0.187920078633842,0.0225979817806517
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1598.Average weekly spirits intake,44681,0.0306369455834344,0.0415933239276526,-0.0508859693147647,0.112159860481633,0.461386983994603
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1608.Average weekly fortified wine intake,44724,0.138349258448362,0.0627857630836438,0.0152891628044203,0.261409354092304,0.0275732217091135
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1737.Childhood sunburn occasions,45718,-0.0012541547747891,0.0405151548657474,-0.080663858311654,0.0781555487620758,0.97530564059208
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1807.Father's age at death,49798,0.00011569201022091,0.00261914755318971,-0.00501783719403093,0.00524922121447275,0.964768025953354
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1845.Mother's age,32547,0.0085066727589884,0.0120977906753156,-0.0152049969646303,0.0322183424826071,0.482005363984138
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1873.Number of full brothers,51506,0.0581540110721614,0.0320458621933619,-0.00465587882682786,0.120963900971151,0.0695816009076335
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1883.Number of full sisters,51512,0.0412907937101737,0.0320192873036241,-0.0214670094049295,0.104048596825277,0.197216818392277
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20015.Sitting height,51757,-0.00802629941589192,0.00349185233971739,-0.014870330001738,-0.00118226883004584,0.0215379381960337
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20016.Fluid intelligence score,36617,-0.0536442927952962,0.0529434938445154,-0.157413540730546,0.050124955139954,0.310980176665674
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20018.Prospective memory result,36976,0.045706559402997,0.0646691796962521,-0.0810450328016571,0.172458151607651,0.479727477707112
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36500,0.00530797514094768,0.00468669004964963,-0.00387793735636559,0.0144938876382609,0.257434676594752
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36486,0.0031777795346679,0.00470845010308529,-0.00605078266737926,0.0124063417367151,0.499754415387786
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20023.Mean time to correctly identify matches,51619,-0.000176368418852135,0.00284914964884228,-0.00576070173058301,0.00540796489287874,0.950641326590331
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48523,-0.0119058269964202,0.00594842160494169,-0.0235647333421059,-0.000246920650734438,0.045351378854432
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48083,0.00493146969080595,0.0126258663698935,-0.0198152283941852,0.0296781677757971,0.696108672881771
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48049,0.0119126749468912,0.0169175647116448,-0.0212457518879327,0.0450711017817151,0.48134173952311
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48056,0.0040578127808056,0.0161675974851659,-0.0276306782901196,0.0357463038517308,0.801828998538008
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48079,-0.00306215627089821,0.0111788983640358,-0.0249727970644083,0.0188484845226119,0.784146867755983
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48251,-0.0232220743486217,0.00745738651859835,-0.0378385519250745,-0.00860559677216893,0.00184862043506586
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48197,0.00221712597432918,0.00911495646861302,-0.0156481887041523,0.0200824406528107,0.807821770333485
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48098,0.0240981124194386,0.0118522359590987,0.000867729939605225,0.047328494899272,0.0420450158992536
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48250,0.00414320848205862,0.00804792989536647,-0.0116307341128597,0.0199171510769769,0.606687105266215
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48235,-0.0149762809470121,0.00749055495883739,-0.0296577686663334,-0.000294793227690805,0.0455841063032293
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48121,0.0239626281330212,0.0106964396431297,0.00299760643248707,0.0449276498335554,0.0250866831770493
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49624,-0.009734892678295,0.00646570898355146,-0.0224076822860559,0.00293789692946587,0.132180532280256
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49469,0.00162946025743725,0.0083968035029309,-0.0148282746083073,0.0180871951231818,0.846133030553617
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49380,-0.0353470028457315,0.0186121650667414,-0.0718268463765448,0.00113284068508167,0.0575610505969901
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49406,0.00701139213363712,0.0116442864492281,-0.01581140930685,0.0298341935741242,0.547093335722522
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49561,0.00389507453411583,0.00707660074914909,-0.00997506293421638,0.017765212002448,0.582040088603916
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49426,-0.0049959494017584,0.013565793545725,-0.0315849047513795,0.0215930059478627,0.712671671859864
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49412,0.00652688968623829,0.0114460614144595,-0.0159073906861023,0.0289611700585789,0.56852792405195
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49416,0.000490936135114957,0.0100795837242368,-0.0192650479643893,0.0202469202346192,0.961154080764677
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49458,0.00619089327064639,0.0113371718045151,-0.0160299634662032,0.028411750007496,0.585023597961637
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49602,0.000234209283474354,0.00628907798919653,-0.0120923835753509,0.0125608021422996,0.970293500026215
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49473,0.00952270286306117,0.00965623526297169,-0.00940351825236334,0.0284489239784857,0.324060786424346
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,45884,-0.00855198007256647,0.00816170467158841,-0.0245489212288797,0.00744496108374681,0.294737697131745
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,45710,0.0255751895214394,0.0284041825080033,-0.0300970081942471,0.0812473872371259,0.367919358208419
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,45702,0.0514971224880194,0.0302465655211777,-0.00778614593348879,0.110780390909528,0.0886659861608643
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,45732,-0.000838815327251748,0.0124411964804811,-0.0252235604289947,0.0235459297744912,0.946246252075824
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,45727,0.00723723545212816,0.016776320837104,-0.0256443533885956,0.0401188242928519,0.666186180304686
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,45760,0.00386437725220459,0.0135938288811434,-0.0227795273548364,0.0305082818592456,0.776203672794597
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,45723,0.00843542413079733,0.0151128243017277,-0.0211857115005889,0.0380565597621835,0.576740427988998
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,45716,0.0300140286231565,0.0153645339804428,-0.000100457978511284,0.0601285152248244,0.0507817649113382
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,45739,0.0106152663437499,0.0124788951166075,-0.0138433680848008,0.0350739007723007,0.394971921004744
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,45755,0.0123571119793967,0.0146522657541179,-0.0163613288986743,0.0410755528574677,0.399040188857064
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,45923,-0.0105720564692657,0.00685436373284719,-0.0240066093856462,0.00286249644711477,0.122999380745379
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,45820,0.0152510349653737,0.00944625154544655,-0.00326361806370151,0.0337656879944489,0.106436574033203
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20127.Neuroticism score,47038,-0.0149910496256094,0.0335929019193471,-0.0808331373875298,0.0508510381363109,0.655417418794305
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36617,0.0359295293374666,0.0531629516715657,-0.0682698559388021,0.140128914613735,0.499164753027486
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20161.Pack years of smoking,36890,0.0199725557509848,0.00459698338399199,0.0109624683183605,0.0289826431836091,1.41250756005588e-05
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36890,0.0205677051202522,0.0047500436593125,0.0112576195479997,0.0298777906925047,1.50996610034821e-05
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20191.Fluid intelligence score,34261,0.0192244792854358,0.0642358680779821,-0.106677822147409,0.145126780718281,0.76473908877423
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34262,-0.00897909356635012,0.0656935684007959,-0.13773848763191,0.11978030049921,0.891288017976994
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20240.Maximum digits remembered correctly,33628,-0.0391114409943934,0.0699456179587614,-0.176204852193566,0.097981970204779,0.576074486499832
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20255.Spirometry QC measure,45978,0.0294354836032671,0.0425969270029622,-0.0540544933225388,0.112925460529073,0.489560240002359
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20261.avMSE,34259,0.0056924404237217,0.00523298568310575,-0.00456421151516557,0.015949092362609,0.276735287361487
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20262.Myopia diagnosis,34259,-0.0908497837026189,0.0836889773790023,-0.254880179365463,0.0731806119602256,0.277723382344651
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20280.Glucose-lactate,42324,0.014953316033354,0.00343619718459023,0.00821836955155712,0.0216882625151508,1.36103905893305e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42351,0.0114079144291228,0.00353265019615748,0.00448392004465413,0.0183319088135914,0.00124407141245469
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36277,-0.0665889955508757,0.0223947183768922,-0.110482643569584,-0.0226953475321669,0.00295489196665861
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36277,-0.0609733644365452,0.0420861974073701,-0.143462311354991,0.0215155824819001,0.147445134427768
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36277,-0.0426169509598821,0.073293625287064,-0.186272456522528,0.101038554602763,0.560952285471374
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36277,-0.0547247354188171,0.0205721290622948,-0.0950461083809149,-0.0144033624567193,0.00782842161979673
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36277,-0.0539240508859959,0.0429797582880354,-0.138164377130545,0.0303162753585535,0.209651491017056
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36280,0.0569111355985577,0.0542646445694532,-0.0494475677575705,0.163269838954686,0.294319719988893
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36280,-0.0449254647662164,0.0334137096005466,-0.110416335583288,0.0205654060508549,0.178822712197705
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36280,-0.0052687711828633,0.0411143345336018,-0.0858528668687228,0.0753153245029962,0.898034497124819
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36280,-0.00937062885495277,0.0623792995381088,-0.131634055949646,0.11289279823974,0.880595190232411
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36280,-0.0322114341879399,0.0732235387156773,-0.175729570070667,0.111306701694788,0.660019000518222
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36280,-0.0312095925702238,0.043517266017154,-0.116503433963846,0.054084248823398,0.473288382378183
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36280,0.0659375709246216,0.0772952727394699,-0.0855611636447394,0.217436305493983,0.393654395044213
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36280,0.0216008947341326,0.0542864002263441,-0.0848004497095018,0.128002239177767,0.690711323115639
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36279,-0.0210645951382665,0.0745099441073683,-0.167104085588708,0.124974895312175,0.777408552325025
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36279,-0.0822697161946591,0.027844575351662,-0.136845083883917,-0.0276943485054016,0.00314099901451085
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36279,-0.072191193214614,0.0510564292293854,-0.172261794504209,0.0278794080749815,0.157420779908546
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36281,-0.113090570897224,0.0861041825374112,-0.28185476867055,0.055673626876102,0.189085485332227
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20600.Liking for adding salt to foods,36114,0.100982479224657,0.0556886087068637,-0.00816719384079596,0.21013215229011,0.0698224862850618
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20601.Liking for aniseed,36114,0.0174185484594846,0.0558407019329483,-0.0920292273290941,0.126866324248063,0.755100977943387
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20602.Liking for apple juice,36114,0.0614257970508203,0.0559596395278415,-0.048255096423749,0.17110669052539,0.272382332939257
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20603.Liking for apples,36114,-0.00907933313528533,0.0573077255934356,-0.121402475298419,0.103243809027849,0.874121639947725
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20604.Liking for asparagus,36114,-0.0607792671490168,0.056708044390855,-0.171927034155093,0.050368499857059,0.283850585351681
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20605.Liking for aubergine,36114,-0.142353114562091,0.0558808381489571,-0.251879557334047,-0.032826671790135,0.010873106527451
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20606.Liking for avocados,36114,-0.0537062283166937,0.0566533559997882,-0.164746806076279,0.0573343494428912,0.34317296244375
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20607.Liking for bacon,36114,0.110895839520851,0.0559915780500074,0.00115234654283612,0.220639332498865,0.0476779012832046
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20608.Liking for baked or steamed fish,36114,-0.131364057347106,0.0564242429565773,-0.241955573541997,-0.020772541152214,0.0199328894551341
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20609.Liking for bananas,36114,0.0151770104473674,0.0576707674995474,-0.0978576938517454,0.12821171474648,0.792430143235473
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36114,-0.0628108337999548,0.0556063050200749,-0.171799191639302,0.046177524039392,0.258699544011534
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20611.Liking for beef steak,36114,0.0708021989740249,0.0554968456442475,-0.0379716184887003,0.17957601643675,0.202073416582595
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20612.Liking for beetroot,36114,-0.0520006020847692,0.0568837580740793,-0.163492767909965,0.0594915637404263,0.360667018268102
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20613.Liking for bell pepper,36114,-0.0753656432305261,0.0558840160636085,-0.184898314715199,0.0341670282541466,0.17750703070838
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20614.Liking for bicycling,36114,-0.0861371813053812,0.0552952415812912,-0.194515854804712,0.0222414921939496,0.119333942902117
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20615.Liking for biscuits,36114,0.127751597759036,0.0558915315646107,0.0182041958923989,0.237298999625673,0.0223016109430939
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20616.Liking for bitter foods,36114,-0.0195279913438308,0.0554506152477605,-0.128211197229441,0.0891552145417798,0.724722213076203
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20617.Liking for bitter or ale,36114,8.09558124413346e-05,0.0571354250823545,-0.111904477348974,0.112066388973856,0.998869509860609
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20618.Liking for black olives,36114,-0.143812082826745,0.0557363605328781,-0.253055349471187,-0.0345688161823044,0.0098941793594785
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20619.Liking for black pepper,36114,-0.0190655537894754,0.0564506949367568,-0.129708915865519,0.0915778082865679,0.735570773645087
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20620.Liking for blue cheese,36114,-0.0165405331716213,0.0560016372507933,-0.126303742183176,0.0932226758399336,0.767729264996784
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20621.Liking for bolognese sauce,36114,0.0898636948965146,0.0559392566477532,-0.0197772481330817,0.199504637926111,0.10822045922974
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20622.Liking for broad beans,36114,-0.043150878078478,0.0556767375091456,-0.152277283596403,0.0659755274394474,0.438351248424009
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20623.Liking for broccoli,36114,-0.128463614590681,0.0575874179006513,-0.241334953675957,-0.0155922755054043,0.0257291064017886
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20624.Liking for brown rice,36114,-0.125590322231309,0.0560631607501781,-0.235474117301659,-0.0157065271609603,0.025112341609965
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20625.Liking for brussel sprouts,36114,-0.0113903713352861,0.0565761647664451,-0.122279654277519,0.0994989116069464,0.840447962615465
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20626.Liking for burgers (meat),36114,0.0452149551398425,0.0556567204732735,-0.0638722169877736,0.154302127267459,0.416595947062405
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20627.Liking for burn of spicy foods,36114,0.0376399948310525,0.0556729989444147,-0.0714790831000003,0.146759072762105,0.499005707379033
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20628.Liking for butter on bread,36114,0.200025878260276,0.0564412442902626,0.0894010394513616,0.310650717069191,0.000396759674927159
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20629.Liking for butternut squash,36114,-0.0981175051022765,0.055926665161144,-0.207733768818119,0.0114987586135657,0.0794070293159685
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20630.Liking for cabbage,36114,0.00431328496238805,0.0566901614397106,-0.106799431459445,0.115426001384221,0.939353479254549
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20631.Liking for cake,36114,0.110085590728661,0.055740383532344,0.000834439005266863,0.219336742452056,0.0483112773266241
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20632.Liking for cake icing,36114,0.0600842145760394,0.0553827438884335,-0.0484659634452903,0.168634392597369,0.278007984071095
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20633.Liking for capers,36114,0.0100721429313145,0.0554948566085804,-0.098697776021503,0.118842061884132,0.85598291011714
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20634.Liking for cauliflower,36114,0.0115554847259791,0.0570176302993848,-0.100199070660815,0.123310040112773,0.839402755640185
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20635.Liking for cereal or granola bar,36114,-0.0666729926517212,0.0555178868157447,-0.175488050810581,0.0421420655071384,0.229820234321394
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20636.Liking for cheesecake,36114,0.0271009192725883,0.0554015646502433,-0.0814861474418887,0.135687985987065,0.624735134325965
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20637.Liking for cherries,36114,-0.0471623509941225,0.0596455699503394,-0.164067668096788,0.0697429661085427,0.429140348545772
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20638.Liking for chicken,36114,-0.0165238957008588,0.0585432253867249,-0.13126861745884,0.098220826057122,0.777759352456588
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20639.Liking for chilli pepper,36114,0.0240502195221945,0.0558599129935893,-0.0854352099452406,0.133535648989629,0.666812493013954
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20640.Liking for chips or french fries,36114,0.121752003906346,0.0562611045156687,0.0114802390556357,0.232023768757057,0.0304944379770798
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20641.Liking for cigarette smoking,36114,0.00281953294953245,0.0957826775789435,-0.184914515105197,0.190553581004262,0.976517094769527
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20642.Liking for cod,36114,-0.121979954158453,0.0579991038702464,-0.235658197744136,-0.00830171057277056,0.0354900169704696
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20643.Liking for coffee with sugar,36114,0.0333164671580969,0.0612311172465543,-0.0866965226451495,0.153329456961343,0.586383288032775
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20644.Liking for coffee without sugar,36114,0.0165555342348903,0.0570829726735689,-0.0953270922053049,0.128438160675085,0.771805208878022
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20645.Liking for coriander,36114,-0.063642032048111,0.0557277629697033,-0.17286844746873,0.0455843833725075,0.253486672372376
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20646.Liking for corn flakes,36114,0.117521561380509,0.0556122276099134,0.00852159526507872,0.226521527495939,0.0346166298403877
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20647.Liking for cream,36114,0.170295322911927,0.0553464154803049,0.0618163485705297,0.278774297253325,0.00209984634951331
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20648.Liking for croissant,36114,0.0784549344419114,0.0557752295733323,-0.0308645155218198,0.187774384405643,0.159583036834423
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20649.Liking for cucumber,36114,0.075952096137357,0.056195963941033,-0.0341919931870676,0.186096185461782,0.176561038044315
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20650.Liking for curry,36114,0.00582429943655354,0.0560817267141002,-0.104095884923083,0.11574448379619,0.91728839858235
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20651.Liking for dairy products,36114,0.110747178504683,0.0567289883099327,-0.000441638582784884,0.221935995592151,0.050953014734973
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20652.Liking for dark chocolate,36114,-0.196524723791605,0.0566091156542153,-0.307478590473867,-0.0855708571093431,0.000520513520979424
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36114,0.000709879037098378,0.0580889415240877,-0.113144446350114,0.11456420442431,0.99025000420066
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20654.Liking for dried fruit,36114,-0.0862644349086013,0.055843209267989,-0.19571712507386,0.0231882552566572,0.122449770292592
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20655.Liking for eggs,36114,0.0493796881402829,0.0572310510452543,-0.0627931719084155,0.161552548188981,0.388270294349417
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20656.Liking for exercising alone,36114,-0.0826491163829798,0.0561541905910152,-0.19271132994137,0.0274130971754099,0.141113795322805
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20657.Liking for exercising with others,36114,-0.0608130984162262,0.0555806085934924,-0.169751091259471,0.0481248944270189,0.273930678110593
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36114,-0.0624303207551722,0.0561087544917641,-0.17240347955903,0.0475428380486854,0.265890471068171
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20659.Liking for fatty foods,36114,0.15118277793067,0.0560430312943119,0.0413384365938183,0.261027119267521,0.00700067205896223
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20660.Liking for fresh tomatoes,36114,0.0200653265599009,0.0597180863319174,-0.0969821226506571,0.137112775770459,0.736880440991686
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20661.Liking for fried chicken,36114,0.0868846737878756,0.0554264093078436,-0.0217510884554979,0.195520436031249,0.117027732991148
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20662.Liking for fried or battered fish,36114,0.0629118195162044,0.0558975046900168,-0.0466472896762286,0.172470928708637,0.260422529037942
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20663.Liking for fruit,36114,-0.0494904235901844,0.0635968959805637,-0.174140339712089,0.0751594925317205,0.436484067850651
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20664.Liking for garlic,36114,-0.0445684421060191,0.0562214652253111,-0.154762513947629,0.0656256297355906,0.427962359773556
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20665.Liking for gherkins,36114,0.0634821900542794,0.0558291230243743,-0.0459428910734942,0.172907271182053,0.255544185508207
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20666.Liking for globe artichoke,36114,-0.0651508249067122,0.0555125584135071,-0.173955439397186,0.0436537895837618,0.240586439519512
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20667.Liking for goat's cheese,36114,-0.0785968996480892,0.0556302149579545,-0.18763212096568,0.0304383216695016,0.157746184884884
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20668.Liking for going to a cafe,36114,0.0473063948363646,0.0559741366570355,-0.062402913011425,0.157015702684154,0.398057815836663
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20669.Liking for going to the gym,36114,-0.059035287951535,0.0553339389523733,-0.167489808298187,0.0494192323951167,0.286058274211511
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20670.Liking for going to the pub,36114,-0.0520477213616139,0.0555482110030123,-0.160922214927518,0.0568267722042902,0.34880011819549
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20671.Liking for grapefruit,36114,0.0148499490355733,0.0555294609895196,-0.0939877945038851,0.123687692575032,0.789150169555074
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20672.Liking for green olives,36114,-0.0996862636669256,0.0558538683961815,-0.209159845723441,0.00978731838959022,0.0743426113566374
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20673.Liking for haddock,36114,-0.0606473775866784,0.0577229019745111,-0.17378426545672,0.0524895102833634,0.29344965269302
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20674.Liking for ham,36114,0.110760095324313,0.0558041480257937,0.00138396519375719,0.220136225454869,0.0472061581299683
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20675.Liking for hard cheese,36114,0.0245188481865732,0.0569932626488453,-0.0871879466051636,0.13622564297831,0.66705915284879
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20676.Liking for herring,36114,-0.125579228289278,0.0553083255336551,-0.233983546335242,-0.0171749102433142,0.0232060712984645
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20677.Liking for honey,36114,0.022772484263745,0.0561529697387048,-0.0872873364241165,0.132832304951607,0.68509044204833
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36114,-0.0485529213886253,0.05578282522047,-0.157887258820747,0.0607814160434959,0.384116481334719
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20679.Liking for ice cream,36114,0.122504076642803,0.0559977607642817,0.0127484655448112,0.232259687740795,0.0287277400478107
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20680.Liking for jam,36114,0.0721010196245897,0.0561155987094026,-0.0378855538458393,0.182087593095019,0.19888220771484
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20681.Liking for kiwi fruit,36114,-0.0991965126433029,0.0562524071710531,-0.209451230698567,0.0110582054119612,0.0778741828138949
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20682.Liking for lager,36114,0.0121490448143981,0.0566131859746091,-0.0988127996958358,0.123110889324632,0.830087521086812
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20683.Liking for lamb,36114,0.0408484725766953,0.0559325092129153,-0.0687792454806186,0.150476190634009,0.465221082422809
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20684.Liking for lemons,36114,0.0294783890450972,0.0557561564015987,-0.0798036775020363,0.138760455592231,0.597029197065363
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20685.Liking for lentils or beans,36114,-0.0700856997373246,0.0561901163002448,-0.180218327685804,0.0400469282111552,0.212331298183544
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20686.Liking for liver,36114,-0.0547424839675059,0.0554795325421691,-0.163482367750157,0.0539973998151455,0.323816943834883
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20687.Liking for mackerel,36114,-0.149971760060256,0.0561605105410305,-0.260046360720676,-0.0398971593998366,0.00759353238634623
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20688.Liking for marzipan,36114,-0.0304753732605388,0.0551356896372751,-0.138541324949598,0.0775905784285204,0.580463407629788
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20689.Liking for mayonnaise,36114,0.125978220710397,0.0557321355020572,0.0167432351263647,0.235213206294429,0.0238259696642577
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20690.Liking for melon,36114,-0.00705352424954658,0.057653154566086,-0.120053707199075,0.105946658699982,0.902630051878918
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20691.Liking for milk chocolate,36114,0.176270934480242,0.0558476536351957,0.0668095333552587,0.285732335605226,0.00160480962179429
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20692.Liking for mushrooms,36114,0.0409142264919702,0.0576283476789837,-0.0720373349588379,0.153865787942778,0.477748539416567
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20694.Liking for orange juice,36114,0.224469706434223,0.0559542117266532,0.114799451449983,0.334139961418464,6.09273244990765e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20695.Liking for oranges,36114,-0.0735054176437042,0.0573829714808704,-0.18597604174621,0.0389652064588018,0.20024992482776
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20696.Liking for pasta,36114,-0.0547905321086971,0.0564176587737963,-0.165369143305338,0.0557880790879436,0.331502961935261
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20697.Liking for pears,36114,0.0139310870893874,0.0575262135947332,-0.0988202915562896,0.126682465735065,0.808656111103462
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20698.Liking for pizza,36114,-0.00488116785745443,0.055878033135813,-0.114402112803648,0.104639777088739,0.930392689334671
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20699.Liking for plain yogurt,36114,-0.119638554275093,0.056224328871338,-0.229838238862915,-0.0094388696872703,0.0333824308340446
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20700.Liking for plums,36114,-0.0863203898461155,0.0574307715628969,-0.198884702109393,0.0262439224171625,0.132876023998785
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20701.Liking for pollock,36114,-0.0558104923694279,0.0550665965919049,-0.163741021689561,0.0521200369507056,0.31085257056568
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20702.Liking for pork chop,36114,0.101794529170017,0.05525831222279,-0.00651176278665189,0.210100821126685,0.0654948903132473
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20703.Liking for porridge,36114,-0.0962634129645558,0.0569883261171859,-0.20796053215424,0.0154337062251285,0.091230478198246
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20704.Liking for potato crisps,36114,0.0684901493120143,0.0559620676328611,-0.0411955032483935,0.178175801872422,0.221043981769831
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20705.Liking for potatoes,36114,0.260813819017762,0.0569378975548139,0.149215539810327,0.372412098225197,4.71611232686145e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20706.Liking for prawns,36114,0.00288645698785491,0.0566956640371722,-0.108237044525003,0.114009958500713,0.959397573644378
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20707.Liking for raw carrots,36114,0.0128221466241279,0.0563793307994957,-0.0976813417428837,0.12332563499114,0.82009894340929
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20708.Liking for red meat,36114,0.100667585361377,0.0557816384281365,-0.00866442595777039,0.209999596680525,0.0711694682329877
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20709.Liking for red wine,36114,-0.101811293788344,0.0563733963876651,-0.212303150708167,0.00868056313147963,0.0709592244651934
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36114,0.109376530140277,0.0576393352998772,-0.00359656704748262,0.222349627328036,0.0577901397818941
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20711.Liking for roast chicken,36114,-0.0565252980878606,0.0583113784283602,-0.170815599807447,0.0577650036317254,0.332394562053021
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20712.Liking for salad dressing,36114,0.0379175973263237,0.0553048894930377,-0.0704799860800302,0.146315180732678,0.492981933351112
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20713.Liking for salad leaves,36114,-0.0533981783777586,0.0569894253137405,-0.16509745199269,0.0583010952371728,0.348799541320136
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20714.Liking for salami,36114,-0.0365676758330763,0.0553239636700162,-0.145002644626308,0.0718672929601555,0.508651318458601
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20715.Liking for salmon,36114,-0.185477288045497,0.0591965964469664,-0.301502617081551,-0.0694519590094423,0.00173609647109977
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20716.Liking for salty foods,36114,0.0978161287174001,0.0554857603263367,-0.0109359615222198,0.20656821895702,0.0779606904030351
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20717.Liking for salty pretzels,36114,0.0306051502240808,0.0555716569963902,-0.0783152974888439,0.139525597937006,0.581834460822311
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20718.Liking for sardines,36114,-0.160236237496622,0.0556654449309113,-0.269340509561208,-0.0511319654320361,0.00400722908184108
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20719.Liking for sausages (meat),36114,0.142956241587425,0.0557660072023303,0.0336548674708574,0.252257615703992,0.0103831934347041
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20720.Liking for savoury biscuits,36114,0.141843903859907,0.0564339083955136,0.0312334434047008,0.252454364315114,0.0119781728845771
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36114,-0.0210658241282565,0.0553934117983493,-0.129636911253021,0.087505262996508,0.703738313499546
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20722.Liking for skimmed milk,36114,-0.0473767239732015,0.0557546213157496,-0.156655781752071,0.0619023338056677,0.395501163381363
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20723.Liking for smoked fish,36114,-0.13232138711098,0.0561194144885468,-0.242315439508532,-0.0223273347134283,0.0184086276511922
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20724.Liking for soft cheese,36114,-0.0125476740585233,0.055586130987699,-0.121496490794413,0.0964011426773668,0.82141506611923
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20725.Liking for soy sauce,36114,0.0504497266353052,0.0560800072432322,-0.0594670875614299,0.16036654083204,0.368363056720886
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20726.Liking for soya milk,36114,-0.117631505209865,0.0561483361089855,-0.227682243983477,-0.00758076643625356,0.0362061278401388
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20727.Liking for spicy foods,36114,-0.0224185002193463,0.0557047668731682,-0.131599843290756,0.0867628428520633,0.687363783186762
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20728.Liking for spinach,36114,-0.111690000568244,0.0564271686043067,-0.222287251032685,-0.00109275010380286,0.0478144701855373
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20729.Liking for spirits,36114,-0.0518466583222522,0.055634024188663,-0.160889345732032,0.0571960290875273,0.351408580800816
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20730.Liking for strawberries,36114,-0.0412393296289677,0.0608874463657104,-0.16057872450576,0.0781000652478247,0.498235570396436
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36114,0.0543274990450084,0.0570306471902458,-0.0574525694478735,0.16610756753789,0.340825163088904
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20732.Liking for sweet foods,36114,0.131834566981828,0.055738335611835,0.0225874291826314,0.241081704781025,0.0180458270488303
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20733.Liking for taking the stairs,36114,-0.131488948096496,0.0562419308920399,-0.241723132644894,-0.021254763548098,0.0194199502526711
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20734.Liking for tea with sugar,36114,0.039387718123824,0.06854202835036,-0.0949546574428816,0.17373009369053,0.565546324066557
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20735.Liking for tea without sugar,36114,-0.0725000700719361,0.0586123186061945,-0.187380214540077,0.042380074396205,0.216150446289791
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20736.Liking for tomato ketchup,36114,0.099438687951563,0.0555199811011841,-0.00938047500675779,0.208257850909884,0.0733300989997044
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20737.Liking for tinned tuna,36114,-0.161659442244271,0.0558436555798454,-0.271113007180768,-0.0522058773077739,0.00380518232527707
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20738.Liking for turnip (white),36114,0.0712275233387837,0.0557283087655791,-0.0379999618417513,0.180455008519319,0.201249680559504
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20739.Liking for vegetables,36114,-0.0351376641239665,0.0613781485372036,-0.155438835256886,0.0851635070089525,0.567016539056413
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20740.Liking for vinegar,36114,0.060183657693848,0.0562406281344824,-0.0500479734497375,0.170415288837433,0.28460717718393
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20741.Liking for watching television,36114,0.133569668296585,0.0562052205627697,0.0234074359935565,0.243731900599614,0.0175065621711615
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20742.Liking for whisky,36114,-0.00730201608554506,0.0574561715189018,-0.119916112262593,0.105312080091502,0.898874086041259
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20743.Liking for white bread,36114,0.250607267003617,0.0552385533121205,0.142339702511861,0.358874831495373,5.80743060609541e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20744.Liking for white rice,36114,0.145127696590597,0.0557619995751548,0.0358341774232939,0.254421215757901,0.0092710045468956
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20745.Liking for white wine,36114,-0.0650225840212817,0.0557849413419049,-0.174361069051415,0.044315901008852,0.243818925409166
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36114,-0.154925285084435,0.0565260085361232,-0.265716261815236,-0.0441343083536336,0.00614512708725307
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20747.Liking for whole milk,36114,0.119232157395154,0.0554099726173683,0.0106286110651126,0.227835703725196,0.0314462547810617
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20748.Liking for wholemeal bread,36114,-0.156308382290985,0.0586384173237927,-0.271239680245619,-0.0413770843363517,0.007702271440898
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20749.Liking for working up a sweat,36114,-0.166206404332564,0.0557593585386566,-0.275494747068331,-0.0569180615967969,0.00288516436618428
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21001.Body mass index (BMI),51813,0.0317157019790289,0.0122840444556731,0.00763897484590957,0.0557924291121482,0.00983312966876957
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21002.Weight,51832,-0.00512167247848917,0.00659410199526206,-0.0180461123892028,0.00780276743222448,0.43734090782001
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36936,0.0170339114415954,0.00438277007396179,0.00844368209663025,0.0256241407865605,0.000102522256239778
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35920,0.00872350175192844,0.0596111275894167,-0.108114308323328,0.125561311827185,0.88365725549011
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35936,0.0751825379801194,0.0607356391788711,-0.0438593148104679,0.194224390770707,0.215809148501459
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35938,-0.0451989929441824,0.0602223226193299,-0.163234745278069,0.0728367593897042,0.452958428242497
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21040.Satisfaction with bowel habits,35895,-0.00660020990451077,0.0559014255450779,-0.116167003972863,0.102966584163842,0.906016749367663
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35876,0.0559370017421116,0.0598621974592864,-0.0613929052780898,0.173266908762313,0.350116210632387
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21042.Greatest number of times bowels opened per day,35897,0.0360351499601367,0.0592016919956267,-0.0800001663512916,0.152070466271565,0.542754238178538
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21043.Least number of times bowels opened per week,35829,0.0785954897787181,0.0602908245973959,-0.0395745264321778,0.196765505989614,0.192413138196608
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21044.Average number of times bowels opened per day,35862,0.0504602121685679,0.0669344126389813,-0.0807312366038355,0.181651660940971,0.45095064916076
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35942,0.054831039557726,0.0607401968368494,-0.0642197462424988,0.173881825357951,0.366709811967706
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35937,-0.0469320493458075,0.0612802448353443,-0.167041329223082,0.0731772305314674,0.443786798048126
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32737,0.176914754559853,0.106070420755293,-0.0309832701205203,0.384812779240227,0.0954241611000916
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35940,0.00833278292857954,0.0694614653233646,-0.127811689105215,0.144477254962374,0.904516291254232
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35940,0.00821629487350813,0.0910103924252646,-0.170164074280011,0.186596664027027,0.928068470568357
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35939,-0.027879046744853,0.0698146916919827,-0.164715842461139,0.108957748971433,0.68966328051991
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35939,0.140078576364798,0.17560441582202,-0.204106078646362,0.484263231375957,0.425076213152967
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35943,0.181889600011949,0.0713290390536751,0.0420846834667461,0.321694516557152,0.0107939624736867
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35940,-0.0439602972015494,0.0657963562728087,-0.172921155496254,0.0850005610931557,0.504075631268643
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35787,0.115218519745338,0.0632420491562322,-0.00873589660087723,0.239172936091553,0.0685206672757565
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35935,0.125089285271066,0.0607169733663586,0.00608401747300337,0.244094553069129,0.0394174470325894
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35940,-0.000121548950418061,0.0966082824153576,-0.189473782484519,0.189230684583683,0.99899616877163
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35944,-0.0951944940920794,0.0608993795511172,-0.214557278012269,0.0241682898281104,0.118065635598165
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35943,-0.0400103334638754,0.0606897268539581,-0.158962198097633,0.0789415311698824,0.509751064649942
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X21100.Water hardness (USGS classification),51782,-0.0238341480729891,0.0319414697210217,-0.0864394287261916,0.0387711325802135,0.455565278064933
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2139.Age first had sexual intercourse,48046,-0.00407727484905568,0.00300631714848264,-0.00996965646008165,0.00181510676197029,0.175040407482145
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2149.Lifetime number of sexual partners,46869,-0.024784711040661,0.0365945360301684,-0.096510001659791,0.0469405795784691,0.498237812369988
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22032.IPAQ activity group,46888,-0.11455844709763,0.0365094026572219,-0.186116876305785,-0.0430000178894748,0.00170512398307806
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22033.Summed days activity,47391,-0.0134940508501542,0.00295587605318824,-0.0192875679144032,-0.00770053378590525,5.02377871062453e-06
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22034.Summed minutes activity,46888,-0.00615671255791784,0.00293252176913083,-0.0119044552254143,-0.000408969890421417,0.0357904857908978
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22037.MET minutes per week for walking,45918,-0.0064963399115049,0.00313858166074327,-0.0126479599665617,-0.0003447198564481,0.0384833022152949
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22038.MET minutes per week for moderate activity,46888,-0.00490913898694707,0.00286182839537596,-0.010518322641884,0.000700044667989812,0.0862920762005799
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22039.MET minutes per week for vigorous activity,46888,-0.153556236671917,0.0365148380457922,-0.225125319241669,-0.0819871541021638,2.6200606783576e-05
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22040.Summed MET minutes per week for all activity,45918,-0.010105185715371,0.00304516434236105,-0.0160737078263987,-0.00413666360434333,0.000907160313781194
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X2217.Age started wearing glasses or contact lenses,49970,0.00572874678308491,0.0024899448479455,0.000848454881111724,0.0106090386850581,0.0214154806675939
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X22501.Year ended full time education,34042,-0.00567380176813278,0.0125854346977322,-0.0303412537756879,0.0189936502394223,0.652137379939274
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X22506.Tobacco smoking,34010,0.147455279017084,0.143507629467114,-0.13381967473846,0.428730232772628,0.304232807878103
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50628,-0.216181871199055,0.120042977885202,-0.451466107854051,0.019102365455942,0.0717373275500921
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23098.Weight,51348,-0.00493818251769419,0.00665972421952659,-0.0179912419879663,0.00811487695257793,0.458398464029206
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23099.Body fat percentage,51340,0.0518905404642413,0.00632496867584282,0.0394936018595894,0.0642874790688932,2.4490191042557e-16
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23100.Whole body fat mass,51325,0.0420338813146955,0.00624339728373593,0.0297968226385731,0.0542709399908179,1.70816567236812e-11
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23101.Whole body fat-free mass,51347,-0.0259580940118498,0.00541601422017208,-0.036573481883387,-0.0153427061403125,1.65501912458863e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23102.Whole body water mass,51348,-0.0266124509987571,0.00543362668435396,-0.0372623593000909,-0.0159625426974234,9.76319048528337e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23104.Body mass index (BMI),51348,0.0301623533353513,0.0122885600370035,0.00607677566282448,0.0542479310078782,0.0141154376855377
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23105.Basal metabolic rate,51348,-0.0259419556454544,0.00578685777980293,-0.0372841968938681,-0.0145997143970406,7.40014957021182e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23106.Impedance of whole body,51345,0.0350000745041834,0.00442437832815286,0.0263282929810038,0.043671856027363,2.67794159735932e-15
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23107.Impedance of leg (right),51348,0.0347409045398149,0.0035621519344928,0.0277590867482091,0.0417227223314208,1.99131974358144e-22
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23108.Impedance of leg (left),51348,0.0328129474460627,0.00354102088747809,0.0258725465066056,0.0397533483855198,2.09358866279408e-20
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23109.Impedance of arm (right),51345,0.0183937207041964,0.00437222649582933,0.00982415677237091,0.0269632846360219,2.59862929525934e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23110.Impedance of arm (left),51348,0.017282805705326,0.00439063164566911,0.00867716767981456,0.0258884437308375,8.30032609612997e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23111.Leg fat percentage (right),51348,0.0720084061182742,0.00741831605927511,0.0574685066420949,0.0865483055944534,3.12222899225286e-22
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23112.Leg fat mass (right),51348,0.0711272306628655,0.00812875012502876,0.0551948804178091,0.0870595809079218,2.2813406478288e-18
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23113.Leg fat-free mass (right),51347,-0.033909622225155,0.00550519362882303,-0.0446998017376481,-0.0231194427126619,7.41990085690748e-10
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23114.Leg predicted mass (right),51347,-0.0334220298655871,0.00553812916294311,-0.0442767630249556,-0.0225672967062186,1.61593209940633e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23115.Leg fat percentage (left),51345,0.0718638705266861,0.00780115799177076,0.0565736008628154,0.0871541401905567,3.47960533881843e-20
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23116.Leg fat mass (left),51345,0.068856481253871,0.00851863352039692,0.052159959553893,0.0855530029538489,6.63789765850001e-16
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23117.Leg fat-free mass (left),51344,-0.0302500442202357,0.00579756000103517,-0.0416132618222646,-0.0188868266182068,1.82770150165613e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23118.Leg predicted mass (left),51344,-0.0304174015011544,0.00583344339935176,-0.0418509505638838,-0.0189838524384249,1.86156512361431e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23119.Arm fat percentage (right),51344,0.0397414517123296,0.00716657460207238,0.0256949654922678,0.0537879379323915,2.96646887449092e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23120.Arm fat mass (right),51342,0.0225477194613738,0.00715023763075087,0.00853325370510209,0.0365621852176455,0.00161583577027338
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23121.Arm fat-free mass (right),51343,-0.0169315049406282,0.00553940930661258,-0.0277887471815889,-0.00607426269966753,0.0022416355298042
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23122.Arm predicted mass (right),51343,-0.0182111260731599,0.00554901699481781,-0.0290871993830028,-0.00733505276331699,0.00103282396776444
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23123.Arm fat percentage (left),51342,0.0418807077745819,0.00733641518377667,0.0275013340143796,0.0562600815347841,1.15360884021266e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23124.Arm fat mass (left),51342,0.0270809944366336,0.00715813672513084,0.0130510464553772,0.0411109424178901,0.000155203314397852
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23125.Arm fat-free mass (left),51342,-0.0185240800602586,0.00565160278773263,-0.0296012215242146,-0.00744693859630268,0.00104829422482736
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23126.Arm predicted mass (left),51340,-0.0162646964579588,0.00565533911181329,-0.0273491611171129,-0.00518023179880476,0.00403147154667402
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23127.Trunk fat percentage,51339,0.0291616741195204,0.00453105943019597,0.0202807976363363,0.0380425506027044,1.25215622328818e-10
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23128.Trunk fat mass,51339,0.0284658713181591,0.00506873836507059,0.0185311441226207,0.0384005985136974,1.97809277292065e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23129.Trunk fat-free mass,51338,-0.0194020580685986,0.00488751294198312,-0.0289815834348856,-0.00982253270231172,7.2184196002276e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23130.Trunk predicted mass,51335,-0.0194053211271686,0.0049016747148713,-0.0290126035683164,-0.00979803868602089,7.5525716347524e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23400.Total Cholesterol,42357,0.0265863700227292,0.00345770151081461,0.0198092750615325,0.0333634649839258,1.58752158923649e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42357,0.037914826178008,0.00334331218974564,0.0313619342861066,0.0444677180699095,1.13503193174412e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42357,0.0406833301620139,0.00333500766439328,0.0341467151398031,0.0472199451842247,4.81130501150281e-34
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23403.VLDL Cholesterol,42357,0.0522539160145621,0.00337481093948361,0.0456392865731743,0.05886854545595,1.33018130709072e-53
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42357,0.0303135350341151,0.00334678826721432,0.023753830030375,0.0368732400378552,1.52063222444815e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23405.LDL Cholesterol,42357,0.034472979458657,0.00336011707750943,0.0278871499867385,0.0410588089305755,1.32816208019791e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23406.HDL Cholesterol,42357,-0.0334446457980558,0.0038564442889294,-0.0410032766043574,-0.0258860149917542,4.72217730972454e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23407.Total Triglycerides,42357,0.0644005136114892,0.00363346360342994,0.0572789249487666,0.0715221022742119,1.74431088899912e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23408.Triglycerides in VLDL,42357,0.0617985793935919,0.0036224137302876,0.0546986484822282,0.0688985103049556,1.45232614108986e-64
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23409.Triglycerides in LDL,42357,0.0655473775307446,0.00360622303290225,0.0584791803862562,0.072615574675233,6.1982384710567e-73
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23410.Triglycerides in HDL,42357,0.0557697503284316,0.00357147442442528,0.048769660456558,0.0627698402003051,1.76276674695223e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42357,0.0312876236903934,0.00358126551108026,0.0242683432886761,0.0383069040921107,2.69301658534974e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23412.Phospholipids in VLDL,42357,0.0607817495529098,0.00347245500707593,0.0539757377390409,0.0675877613667786,7.82287550511781e-68
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23413.Phospholipids in LDL,42357,0.0362770098601234,0.00333766282135615,0.0297351907302654,0.0428188289899815,2.11764809707967e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23414.Phospholipids in HDL,42357,-0.0155522694988078,0.00383798967644692,-0.0230747292646437,-0.00802980973297181,5.1031525741484e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23415.Total Esterified Cholesterol,42357,0.0241218727172228,0.00347658125991274,0.0173077734477938,0.0309359719866517,4.15149650249207e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42357,0.047183646827635,0.00334128433926502,0.0406347295226756,0.0537325641325945,5.9655311114743e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42357,0.0379165911708015,0.0033614646087392,0.0313281205376727,0.0445050618039303,2.25237767163804e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42357,-0.0370098264910667,0.0038346806492072,-0.0445258005635128,-0.0294938524186206,5.73631660653573e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23419.Total Free Cholesterol,42357,0.032249655224889,0.00341370673975268,0.0255587900149738,0.0389405204348043,4.06298781935149e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42357,0.0577397543668618,0.00343588359956078,0.0510054225117227,0.064474086222001,1.01065315687737e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23421.Free Cholesterol in LDL,42357,0.0242464984264128,0.0033722140707081,0.0176369588478249,0.0308560380050006,6.82471707829167e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23422.Free Cholesterol in HDL,42357,-0.019246533367016,0.00390171125357152,-0.0268938874240162,-0.0115991793100158,8.20307288377011e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42357,0.0434562058624684,0.00343597867772645,0.0367216876541245,0.0501907240708122,1.88388295209346e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23424.Total Lipids in VLDL,42357,0.0622564845075665,0.00351726820344858,0.0553626388288073,0.0691503301863257,2.64730032532656e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23425.Total Lipids in LDL,42357,0.0376723734601156,0.00335441740859401,0.0310977153392713,0.0442470315809598,3.91059039212439e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23426.Total Lipids in HDL,42357,-0.0193905852727112,0.0038581398994208,-0.026952539475576,-0.0118286310698464,5.07684751714476e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42357,0.00668665495222327,0.00364833545521986,-0.000464082540007659,0.0138373924444542,0.0668554754890089
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23428.Concentration of VLDL Particles,42357,0.0572073822816896,0.00343129999218469,0.0504820342970076,0.0639327302663716,8.96449830854573e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23429.Concentration of LDL Particles,42357,0.0387540986103912,0.00332345816517979,0.0322401206066388,0.0452680766141436,2.88038894009704e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23430.Concentration of HDL Particles,42357,-0.000908177461771735,0.00365406064226157,-0.00807013632060442,0.00625378139706095,0.803721089054027
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42357,0.0543370660876814,0.00369477596323014,0.0470953051997503,0.0615788269756125,1.42250946190786e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42357,-0.0303397648332242,0.00354267784917799,-0.037283413417613,-0.0233961162488353,1.20952187017949e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42357,-0.0485850890515732,0.00397307408800014,-0.0563723142640535,-0.040797863839093,3.35249157334342e-34
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23434.Phosphoglycerides,42346,0.0268701298177265,0.00365113124593896,0.0197139125756861,0.0340263470597668,1.95703062749973e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42346,0.0626924305246753,0.00378355724747161,0.0552766583196309,0.0701082027297196,4.79075395970039e-61
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23436.Total Cholines,42346,0.0248626044692421,0.00365738344444205,0.0176941329181357,0.0320310760203485,1.10718385216777e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23437.Phosphatidylcholines,42346,0.0246863470560432,0.00368424884773885,0.0174652193144751,0.0319074747976114,2.16151204271619e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23438.Sphingomyelins,42346,0.0151764777633918,0.00359652618327915,0.0081272864441647,0.022225669082619,2.46202782669434e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23439.Apolipoprotein B,42357,0.0404365626652023,0.00332048957777452,0.0339284030927642,0.0469447222376404,6.20592305436376e-34
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23440.Apolipoprotein A1,42357,-0.00992074280822455,0.00376916840881768,-0.0173083128895072,-0.00253317272694189,0.00849635595955901
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42357,0.0413517087437219,0.00339769199933901,0.0346922324250174,0.0480111850624263,6.78512703333093e-34
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23442.Total Fatty Acids,42346,0.050840295568137,0.00353034495935213,0.0439208194478069,0.0577597716884672,1.15528187332565e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23443.Degree of Unsaturation,42346,-0.080199762856438,0.00355254979364601,-0.0871627604519841,-0.0732367652608918,9.51833730000715e-111
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42346,-0.0298101559588792,0.00358287833591275,-0.0368325974972682,-0.0227877144204902,9.64349169587248e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42346,0.0350417147110338,0.00349682937655712,0.0281879291329818,0.0418955002890857,1.49717338120761e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42346,0.0225221641751182,0.00355153489182778,0.0155611557871357,0.0294831725631006,2.3493692128417e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42346,0.0644547275750722,0.00360213571296675,0.0573945415776574,0.0715149135724871,9.12984146985447e-71
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23448.Saturated Fatty Acids,42346,0.0567471870191153,0.00352311024929035,0.0498418909305062,0.0636524831077244,8.11643743144972e-58
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23449.Linoleic Acid,42346,0.0394992951485489,0.00341971199376867,0.0327966596407623,0.0462019306563355,1.03255985639142e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23450.Docosahexaenoic Acid,42346,-0.045652388200677,0.00356489506251824,-0.0526395825232128,-0.0386651938781413,2.53217324410245e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42346,-0.0645086283408823,0.00351064109261275,-0.0713894848824032,-0.0576277717993613,1.77085228958274e-74
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42346,-0.0488160366244668,0.00379091266524253,-0.0562462254483422,-0.0413858478005915,1.02317889986719e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42346,-0.0770384391701698,0.00370707668660009,-0.084304309475906,-0.0697725688644337,2.07951038543722e-94
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42346,0.0705677050780652,0.00376688895588245,0.0631846027245356,0.0779508074315948,2.65963854363451e-77
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42346,0.046383565755113,0.00343752729608064,0.0396460122547949,0.053121119255431,3.21977910525738e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42346,-0.0106959121374339,0.00366693203926693,-0.0178830989343971,-0.00350872534047071,0.00354176987005754
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42346,-0.0752931369055339,0.00348259919318916,-0.0821190313241847,-0.0684672424868832,6.879672537613e-102
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42346,-0.0772257176414011,0.00376522311954389,-0.0846055549557071,-0.0698458803270951,4.77213475054742e-92
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42346,0.0470289698016514,0.00349400583370942,0.040180718367581,0.0538772212357219,5.03106941528273e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23460.Alanine,42351,0.0119387405611359,0.00346042547248757,0.00515630663506026,0.0187211744872115,0.000562180696878498
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23461.Glutamine,42311,-0.0131064589368931,0.00346727430792139,-0.019902316580419,-0.00631060129336717,0.000157493635202898
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23462.Glycine,42341,-0.00520917921237862,0.00368818378104949,-0.0124380194232356,0.00201966099847839,0.157856808946575
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23463.Histidine,42338,-0.00480657609140843,0.00341484741027253,-0.0114996770155426,0.00188652483272573,0.159287348392288
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42348,0.0199562059290765,0.003606640013841,0.0128871915019481,0.0270252203562048,3.20478796344249e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23465.Isoleucine,42353,0.0120627545496633,0.00351381757142303,0.00517567210967418,0.0189498369896524,0.000598893591066511
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23466.Leucine,42353,0.0180348917811405,0.00355581331658313,0.0110654976806375,0.0250042858816434,3.99128038905716e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23467.Valine,42348,0.0221567220856768,0.00364139719575419,0.0150195835819986,0.029293860589355,1.19968754063788e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23468.Phenylalanine,42350,0.00353759708287051,0.0034497883815494,-0.00322398814496632,0.0102991823107073,0.305168176163951
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23469.Tyrosine,42341,0.0108092450912854,0.00350456029957652,0.00394030690411539,0.0176781832784554,0.00204429449380804
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23470.Glucose,42330,0.001263163353972,0.00341868280643009,-0.00543745494663097,0.00796378165457497,0.711769736183069
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23471.Lactate,42332,0.026608470954014,0.00342639591449403,0.0198927349616057,0.0333242069464223,8.71715918629787e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23472.Pyruvate,42315,0.00606201588986109,0.0034621066483005,-0.000723713140807897,0.0128477449205301,0.0799758868890336
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23473.Citrate,42354,0.0163041145495748,0.00346841556150482,0.00950602004902539,0.0231022090501243,2.61851186588236e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23474.3-Hydroxybutyrate,42136,0.0160876665962015,0.00363545899048833,0.0089621669748444,0.0232131662175586,9.71365810156211e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23475.Acetate,42345,-0.0239328738422114,0.00339515330551405,-0.0305873743210189,-0.0172783733634038,1.89024076598904e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23476.Acetoacetate,42355,0.00375568239277966,0.00350257561187781,-0.00310936580650084,0.0106207305920602,0.283621561182126
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23477.Acetone,42355,-0.014378126759888,0.00347183450045435,-0.0211829223807786,-0.00757333113899749,3.47402650867333e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23478.Creatinine,42046,0.0128303357808245,0.0038756029056345,0.00523415408578088,0.0204265174758681,0.000933728338136592
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23479.Albumin,42355,-0.000855698248521996,0.00346696020218704,-0.0076509402448086,0.0059395437477646,0.805055146737305
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23480.Glycoprotein Acetyls,42357,0.0539906953834309,0.00364325209733903,0.0468499212726464,0.0611314694942154,2.73959176091561e-49
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42357,0.0586339015258907,0.0036549768931459,0.0514701468153247,0.0657976562364566,2.26517278132642e-57
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42357,0.0551874298704558,0.00361999969529802,0.0480922304676716,0.0622826292732399,4.93119575083881e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42357,0.0586881794903463,0.00366153980241092,0.0515115614776209,0.0658647975030717,2.82240435738246e-57
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42357,0.0603707654254669,0.00362681451495253,0.0532622089761599,0.0674793218747739,1.38449382398157e-61
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42357,0.0609657537008403,0.0035840124151176,0.0539410893672099,0.0679904180344708,3.32806838841832e-64
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42357,0.057903044047461,0.00366268408542559,0.0507241832400269,0.0650819048548952,8.7977177741919e-56
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42357,0.050889181147776,0.00358807310949353,0.0438565578531687,0.0579218044423834,2.52183099790372e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42357,0.0657353559496233,0.00363154388773842,0.058617529929656,0.0728531819695906,2.3452476481996e-72
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42357,0.0637386210891039,0.00361533676703025,0.0566525610257246,0.0708246811524832,8.92013721040375e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42357,0.0642954151559622,0.00360180397247885,0.0572358793699037,0.0713549509420207,1.92074422366039e-70
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42357,0.0626132280141949,0.00352113574365191,0.0557118019566371,0.0695146540717526,6.37917985611152e-70
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42357,0.0602275369949092,0.00346829820695326,0.0534296725092808,0.0670254014805376,8.39596367398929e-67
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42357,0.0627417146839354,0.0035759807485891,0.0557327924167008,0.0697506369511701,3.8447267212291e-68
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42357,0.0614033418771963,0.00364219343047678,0.0542646427534618,0.0685420410009308,4.14042167165432e-63
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42357,0.0638686766645319,0.00358978598082187,0.0568326961421211,0.0709046571869428,5.39030214137908e-70
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42357,0.0614096912865547,0.00357299172265184,0.0544066275101571,0.0684127550629523,1.71421848099889e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42357,0.064878603593795,0.00358668952598426,0.0578486921228659,0.0719085150647241,2.92636081666904e-72
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42357,0.0611207297088436,0.00351832638141729,0.0542248100012657,0.0680166494164215,7.45874622575624e-67
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42357,0.0563783184850897,0.00346239888111282,0.0495920166781085,0.0631646202920708,4.91300673588927e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42357,0.0644894932034022,0.00357938939820078,0.0574738899829287,0.0715050964238758,1.04102265513182e-71
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42357,0.0571147437785763,0.00357623445225867,0.0501053242521493,0.0641241633050033,6.99872518055912e-57
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42357,0.0506810597279854,0.00338078958888154,0.0440547121337776,0.0573074073221932,2.19240167309388e-50
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42357,0.0539422217605861,0.0034139804881161,0.0472508200038786,0.0606336235172937,1.00460111525797e-55
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42357,0.0495574330303203,0.00336774478640547,0.0429566532489655,0.056158212811675,1.25058331910595e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42357,0.0327137633617313,0.00332322880192735,0.0262002349099537,0.0392272918135089,8.72330716583379e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42357,0.0227256731138705,0.00334012773983124,0.0161790227438013,0.0292723234839397,1.06277568082152e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42357,0.0441168244209302,0.00334930436539747,0.0375521878647512,0.0506814609771093,2.25821594651439e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42357,0.0588449017951622,0.00354328836521174,0.0519000565993472,0.0657897469909773,2.58669615555502e-61
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42357,0.059107659237507,0.00348301001021978,0.0522809596174762,0.0659343588575378,6.50742816591844e-64
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42357,0.0588501817971889,0.0034728096663112,0.0520434748512189,0.0656568887431588,9.75265219410002e-64
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42357,0.0513302125978781,0.00339794892503587,0.0446702327048078,0.0579901924909483,3.95021856877708e-51
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42357,0.0491916065085663,0.00336615554708292,0.0425939416362838,0.0557892713808488,5.46417283600991e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42357,0.0517041736041248,0.00338057718725516,0.0450782423171047,0.0583301048911449,2.34488109371938e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42357,0.0438064942368327,0.00334764397725543,0.037245112041412,0.0503678764322533,6.94237081645436e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42357,0.0594228404944621,0.00361015416665006,0.052346938327828,0.0664987426610962,2.84544153907072e-60
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42357,0.0445978204543076,0.0034092574852588,0.0379156757832003,0.0512799651254148,7.34886223473901e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42357,0.0435416737211757,0.00344403014140219,0.0367913746440274,0.050291972798324,1.99981755879364e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42357,0.0444624498377108,0.00344657209634733,0.03770716852887,0.0512177311465515,7.58298109375651e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42357,0.029758437118231,0.00340930343194431,0.0230762023916201,0.0364406718448418,2.88608231692992e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42357,0.0249886913373723,0.00341684928226377,0.0182916667441353,0.0316857159306093,2.75579061524126e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42357,0.0397637821875352,0.00341965113090938,0.0330612659709528,0.0464662984041175,4.21293709725796e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42357,0.0581036581790874,0.00361059931868465,0.0510268835144654,0.0651804328437093,1.02194579704318e-57
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23523.Concentration of IDL Particles,42357,0.0313656419845839,0.00331426803958465,0.024869676626998,0.0378616073421698,3.4667840525005e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23524.Total Lipids in IDL,42357,0.0263845154911207,0.0034159849995691,0.0196891848919653,0.0330798460902761,1.21018644351014e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23525.Phospholipids in IDL,42357,0.0256024922099346,0.00342475328394535,0.0188899757734017,0.0323150086464675,8.16333259636327e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23526.Cholesterol in IDL,42357,0.0210778757389012,0.00341724240930191,0.0143800806166695,0.027775670861133,7.11418139839177e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42357,0.0214680954470057,0.00341936446743176,0.0147661410908394,0.0281700498031719,3.52849169128167e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23528.Free Cholesterol in IDL,42357,0.0194655794209166,0.00340949077271484,0.0127829775063955,0.0261481813354377,1.15936957491733e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23529.Triglycerides in IDL,42357,0.0580312068094066,0.00361216724272875,0.0509513590136582,0.0651110546051549,1.56798458870896e-57
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42357,0.0332169126192854,0.00332780008444008,0.0266944244537829,0.039739400784788,2.22079374689342e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23531.Total Lipids in Large LDL,42357,0.0328062409525968,0.00337869627986986,0.0261839962440519,0.0394284856611417,3.25344454185111e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23532.Phospholipids in Large LDL,42357,0.0317933639790795,0.00335440224271878,0.0252187355833507,0.0383679923748083,3.02659099024701e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23533.Cholesterol in Large LDL,42357,0.0293482239332397,0.0033886760898418,0.0227064187971498,0.0359900290693296,5.23128706329337e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42357,0.0317720095011948,0.00338711465708325,0.0251332647733117,0.038410754229078,7.64394398038559e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42357,0.0221255403987209,0.00339840043543676,0.0154646755452649,0.028786405252177,7.75802220006051e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23536.Triglycerides in Large LDL,42357,0.0634200701795882,0.00360116802714254,0.0563617808463888,0.0704783595127876,1.24041290534379e-68
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42357,0.0451272152637648,0.00333806135148341,0.0385846150148573,0.0516698155126723,2.28104179832879e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42357,0.0457330893126123,0.00335640527254009,0.0391545349784337,0.0523116436467908,5.43225480275585e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42357,0.0437811408837719,0.00335190966130425,0.0372113979476156,0.0503508838199282,9.50670139332057e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42357,0.0432962968536886,0.00335189722774204,0.0367265782873142,0.049866015420063,6.13947707115596e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42357,0.0477369811715037,0.0033644892882803,0.0411425821664743,0.0543313801765331,2.33094777189683e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42357,0.0292223125342088,0.00335499697198724,0.0226465184691138,0.0357981065993037,3.39545502177659e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42357,0.0672550864944174,0.00360984913814536,0.0601797821836525,0.0743303908051823,1.72962676253372e-76
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42357,0.0457299391841737,0.00331770385177175,0.0392272396347011,0.0522326387336464,6.35278727774537e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23545.Total Lipids in Small LDL,42357,0.0427003242974579,0.00332547329647087,0.036182396636375,0.0492182519585408,1.6354181310758e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23546.Phospholipids in Small LDL,42357,0.0351523178361381,0.00330665584058499,0.0286712723885915,0.0416333632836846,2.73945391039456e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23547.Cholesterol in Small LDL,42357,0.0408046178957367,0.00332712679900203,0.0342834493696927,0.0473257864217807,2.17149302459423e-34
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42357,0.0466235036934207,0.00334121992784785,0.040074712634839,0.0531722947520025,6.11006037091833e-44
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42357,0.0228314765604474,0.00333283234284539,0.0162991251684704,0.0293638279524244,7.68783556474516e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23550.Triglycerides in Small LDL,42357,0.065593860352003,0.0036316072120051,0.058475910216473,0.072711810487533,4.69966355414375e-72
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42357,-0.0257530505904894,0.00382156514639896,-0.0332433182774313,-0.0182627829035474,1.66261890147704e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42357,-0.0374422629194115,0.00383413899661546,-0.0449571753527778,-0.0299273504860452,1.88711738488519e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42357,-0.0409180693522218,0.00385756814896391,-0.0484789029241911,-0.0333572357802525,3.51820368537248e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42357,-0.0385064748322824,0.00379191526272456,-0.0459386287472226,-0.0310743209173423,3.86805865885907e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42357,-0.0412955741193648,0.003828239923876,-0.0487989243701617,-0.0337922238685678,5.1376983894149e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42357,-0.0273657087587034,0.00363735428289934,-0.0344949231531861,-0.0202364943642207,5.67769943229327e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42357,0.0460803240868338,0.00356487856257544,0.039093162104186,0.0530674860694817,5.4525158441812e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42357,-0.043640766166794,0.00397975426184692,-0.0514410845200139,-0.035840447813574,7.37382750682693e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23559.Total Lipids in Large HDL,42357,-0.045473600487746,0.00398488857057714,-0.0532839820860772,-0.0376632188894148,5.06918158601531e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23560.Phospholipids in Large HDL,42357,-0.0438279633928813,0.00398314672564304,-0.0516349309751416,-0.0360209958106209,4.87782233637454e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23561.Cholesterol in Large HDL,42357,-0.0511454085928239,0.00393686668869474,-0.0588616673026656,-0.0434291498829822,2.35577153198243e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42357,-0.0535410688660296,0.00392670848851566,-0.0612374175035203,-0.0458447202285388,4.77877169157615e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42357,-0.0423529542640039,0.00395397828182516,-0.0501027516963812,-0.0346031568316266,1.1578747243274e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23564.Triglycerides in Large HDL,42357,0.0323565031225053,0.00369105781887328,0.0251220297975137,0.039590976447497,2.07263872577939e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42357,-0.014232459392671,0.00373813387871616,-0.0215592017949547,-0.00690571699038736,0.000141089619410319
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42357,-0.0111088037269646,0.00370808676965501,-0.0183766537954884,-0.0038409536584408,0.00274207137478058
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42357,-0.00641113384446369,0.00368999913580871,-0.0136435321506487,0.000821264461721376,0.082333797924652
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42357,-0.0245497844421651,0.00372437321576822,-0.0318495559450708,-0.0172500129392594,4.51528769051193e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42357,-0.0265933096286891,0.00370429005576374,-0.033853718137986,-0.0193329011193922,7.39593919709779e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42357,-0.0152291055231114,0.00379230318499921,-0.0226620197657099,-0.007796191280513,5.95750145037686e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42357,0.0522716142409722,0.00356022277392111,0.0452935776040868,0.0592496508778576,2.02567824062193e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42357,0.0273116157130399,0.00342846926515839,0.0205918159533295,0.0340314154727504,1.77120016179887e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23573.Total Lipids in Small HDL,42357,0.0323754289701675,0.00345082945089494,0.0256118032464135,0.0391390546939216,7.52469998800985e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23574.Phospholipids in Small HDL,42357,0.0303310458319288,0.00347310194082672,0.0235237660279084,0.0371383256359492,2.77337099907304e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23575.Cholesterol in Small HDL,42357,0.0199963723776425,0.0034292729977882,0.0132749973019776,0.0267177474533074,5.63612950302489e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42357,0.0151634862591277,0.00341310894487016,0.00847379272718224,0.0218531797910733,8.95537650012923e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42357,0.032433330202335,0.00350777342443382,0.0255580942904447,0.0393085661142253,2.68130055693369e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23578.Triglycerides in Small HDL,42357,0.0669929996359337,0.00360656977366995,0.0599241228795406,0.0740618763923268,4.76346211889917e-76
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,0.00935343615578736,0.00350428622585413,0.00248503515311327,0.0162218371584615,0.00761421982010667
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,-0.0126782701905584,0.0036104373919375,-0.0197547274787559,-0.00560181290236095,0.000447032052355393
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,-0.000256906935292062,0.00357787603433047,-0.00726954396257978,0.00675573009199566,0.942758771647781
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,-0.0277821371017353,0.00361946057555558,-0.0348762798298242,-0.0206879943736464,1.76445364342644e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,0.00617763847321502,0.00358582605287396,-0.000850580590417949,0.013205857536848,0.0849502197072541
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42237,0.0240386176630679,0.00349138092997653,0.0171955110403139,0.0308817242858219,6.03773945909694e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42237,-0.0271613288266673,0.00365696532449139,-0.0343289808626704,-0.0199936767906642,1.17733065679218e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42237,-0.0278424730607907,0.0036603987196274,-0.0350168545512604,-0.020668091570321,3.01105544489178e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42237,-0.0192489915625136,0.00361755009637909,-0.0263393897514166,-0.0121585933736106,1.04904897912277e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42237,0.0157105590025162,0.00359201183602755,0.00867021580390217,0.0227509022011302,1.23077992022303e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42356,0.0552368010802935,0.00353922230374403,0.0482999253649552,0.0621736767956318,2.00264760118117e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42356,-0.00567114449956797,0.00346699683846095,-0.0124664583029514,0.0011241693038155,0.101915564088756
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42356,-0.0175142047831509,0.00356501799873751,-0.0245016400606764,-0.0105267695056254,9.08665097246067e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42356,0.0242965742886364,0.00341736064489083,0.0175985474246504,0.0309946011526224,1.22252992160993e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42356,-0.0176927088355629,0.00340672617027842,-0.0243698921293086,-0.0110155255418172,2.09496563675269e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42357,0.000525986378502957,0.0034710196282971,-0.00627721209295935,0.00732918484996527,0.87955479439086
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42357,-0.0239875183703279,0.00359938143344732,-0.0310423059798846,-0.0169327307607711,2.76435203009846e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42357,-0.0274295051065158,0.00363364689344365,-0.0345514530176653,-0.0203075571953662,4.68317400886036e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42357,-0.0133286203691059,0.00351508122802847,-0.0202181795760417,-0.00643906116217011,0.00015020415750019
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42357,0.0185839161726482,0.00356954075100471,0.011587616300679,0.0255802160446174,1.95598690551067e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42357,-0.0200949895820296,0.00358713912411041,-0.027125782265286,-0.0130641968987731,2.16197655789742e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42357,-0.00661152370955738,0.00349711680069997,-0.0134658726389293,0.000242825219814565,0.0587044910463938
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42357,0.00355781168730309,0.00342854360735673,-0.0031621337831161,0.0102777571577223,0.299427178536712
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42357,-0.0194617650254733,0.00360143122159746,-0.0265205702198043,-0.0124029598311422,6.63438565125164e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42357,0.0108417098434147,0.0035280682028235,0.00392669616588066,0.0177567235209488,0.00212360393875308
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42357,0.0127345872311979,0.00351425315187975,0.00584665105351359,0.0196225234088822,0.000291516189430758
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42357,-0.0257384743188738,0.00363203586316889,-0.0328572646106848,-0.0186196840270627,1.44534776764043e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42357,-0.027866362692299,0.00366179539525425,-0.0350434816669973,-0.0206892437176007,2.92644365538578e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42357,-0.00443400645260634,0.00344066581294558,-0.0111777114459797,0.00230969854076699,0.197522987340793
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42357,0.0257666706825782,0.00361616948145718,0.0186789784989222,0.0328543628662343,1.09176919271906e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42357,-0.0126447863723848,0.00330979155807061,-0.0191319778262032,-0.00615759491856642,0.000133838087080778
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42357,-0.0139325492912198,0.00350891005484055,-0.0208100129987073,-0.00705508558373234,7.20669345042775e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42357,-0.00869696521630477,0.00350414800527519,-0.0155650953066442,-0.00182883512596539,0.0130805614507215
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42357,-0.0173370424375132,0.0033692579397133,-0.0239407879993513,-0.0107332968756752,2.70423747184241e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42357,0.0251735763434597,0.0036142480165328,0.0180896502310554,0.032257502455864,3.43775831578078e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42357,-0.00931901641945848,0.00335643883472294,-0.0158976365355154,-0.00274039630340151,0.00550321427761248
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42357,-0.0218024422678123,0.00363652693178714,-0.0289300350541151,-0.0146748494815095,2.08296122981152e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42357,0.00494467179836152,0.00339766242925015,-0.00171474656296877,0.0116040901596918,0.145605703173458
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42357,-0.0333863282403598,0.00362692369168651,-0.0404950986760653,-0.0262775578046542,3.92113385197107e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42357,0.024763303434853,0.00362540283913048,0.0176575138701572,0.0318690929995487,8.83387785862291e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42357,-0.0273423987040648,0.00343371828061422,-0.0340724865340686,-0.0206123108740609,1.81759002955044e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42357,-0.00309698174635741,0.00335399384739689,-0.00967080968725532,0.0034768461945405,0.355830654562861
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42357,0.0403748558867339,0.00345173282624346,0.0336094595472967,0.047140252226171,1.88963898082353e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42357,-0.0509492192343034,0.0036868368241977,-0.0581754194097309,-0.0437230190588759,3.90358208696394e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42357,0.0181924068860288,0.00356325368243375,0.0112084296684586,0.0251763841035989,3.34419597034587e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42357,-0.0434208062415874,0.00337865544504165,-0.050042970913869,-0.0367986415693057,1.41885831196929e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42357,0.0113483147185396,0.00342306435791654,0.00463910857702317,0.018057520860056,0.000918086582359127
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42357,0.0438615038908258,0.00338216124360346,0.037232467853363,0.0504905399282885,3.16539051882306e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42357,-0.0400795063417392,0.00362237421180428,-0.0471793597968756,-0.0329796528866028,2.48815772491248e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42357,0.0343829520934717,0.00362457259890561,0.0272787897996167,0.0414871143873267,2.80545227933595e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42348,-0.0452232251581993,0.00376391019886732,-0.0526004891479793,-0.0378459611684194,4.41749550427306e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42348,0.00582482174045398,0.00357767714197898,-0.00118742545782483,0.0128370689387328,0.10352730130888
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42348,-0.0166664097458153,0.00347153236767475,-0.0234706131864578,-0.00986220630517275,1.59708662308072e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42348,0.0418116919630512,0.00394191195298817,0.0340855445351944,0.049537839390908,3.52855941528885e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42348,0.0659225849148672,0.00372683059887232,0.0586179969410774,0.0732271728886569,3.2406597341978e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42357,0.0278669247948458,0.00367035106201339,0.0206730367132996,0.0350608128763921,3.3504963196404e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42357,-0.0549398212553272,0.00377036519356135,-0.0623297370347074,-0.047549905475947,1.00303204153593e-47
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42357,-0.0584925917023869,0.00379060872005658,-0.0659221847936978,-0.051062998611076,2.9652795578319e-53
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42357,-0.0145583569338159,0.00361265158956373,-0.0216391540493608,-0.00747755981827096,5.61321180880782e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42357,0.0652560392751275,0.00371141696255682,0.0579816620285162,0.0725304165217389,2.02644656312457e-68
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42357,0.0382953830620978,0.00372380966933983,0.0309967161101918,0.0455940500140039,1.0326673589466e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42357,-0.0548737313660877,0.00367582468332978,-0.0620783477454141,-0.0476691149867613,5.52972724767139e-50
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42357,-0.0562448882402639,0.00365052467332882,-0.0633999165999884,-0.0490898598805394,4.24433391427971e-53
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42357,-0.0233017327936371,0.00387250577636116,-0.0308918441153049,-0.0157116214719692,1.82146162095483e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42357,0.0613919455116083,0.00361669532008871,0.0543032226842344,0.0684806683389821,6.05579741022497e-64
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42357,-0.0107542968190739,0.00357715883062596,-0.0177655281271008,-0.00374306551104708,0.00264877511502806
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42357,-0.0323756135695686,0.00356674181250797,-0.0393664275220842,-0.025384799617053,1.27196419478658e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42357,-0.0326943483791199,0.00360051504697857,-0.0397513578711979,-0.0256373388870419,1.2333067550668e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42357,0.0018780587774507,0.00357091453643985,-0.00512093371397141,0.00887705126887281,0.59894420678635
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42357,0.0611431539419471,0.00365375765788171,0.053981788932499,0.0683045189513953,3.23447507063604e-62
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51637,-0.00364948713300022,0.00299997388532019,-0.00952943594822779,0.00223046168222735,0.223804905816078
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51637,-0.00262026534233011,0.00292084451912706,-0.00834512059981915,0.00310458991515893,0.369679616035879
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50195,0.000136231607648199,0.00277147176406272,-0.00529585304991473,0.00556831626521112,0.960796265117459
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50195,-4.96561249482016e-05,0.00304545883908638,-0.0060187554495575,0.00591944319966109,0.986991244865743
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50195,-0.00283311869781247,0.00297437092147728,-0.00866288570390795,0.002996648308283,0.340849248239992
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50195,-7.04076288668725e-05,0.00270763081552596,-0.00537736402729775,0.00523654876956401,0.97925486723042
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24009.Traffic intensity on the nearest road,51637,-0.0117658851816636,0.0706422363952668,-0.150224668516386,0.126692898153059,0.867720952419526
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24010.Inverse distance to the nearest road,51637,-0.000562076423946969,0.00262134233818302,-0.00569990740678569,0.00457575455889175,0.830219055536565
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51637,0.00106527000453951,0.00258933854720402,-0.00400983354798036,0.00614037355705938,0.680778616433387
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24012.Inverse distance to the nearest major road,51637,-0.00232602521276323,0.00263502589819787,-0.00749067597323105,0.00283862554770459,0.377389818713363
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24013.Total traffic load on major roads,51637,-0.00357009827932024,0.0493519855923439,-0.100299990040314,0.0931597934816738,0.942332370094537
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51637,-0.0174795937079028,0.048001385136491,-0.111562308575425,0.0766031211596196,0.715751154081426
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51637,-0.00644284144911045,0.00298149170832269,-0.0122865651974229,-0.000599117700797965,0.0307100844352092
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51637,-0.00632436335244626,0.00297496691034932,-0.0121552984967309,-0.000493428208161586,0.0335257992048199
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51637,-0.00630204242981223,0.00294123610483361,-0.0120668651952861,-0.000537219664338368,0.0321518577070311
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51583,-0.00453301213346749,0.00293223747354224,-0.0102801975816103,0.0012141733146753,0.12213739925226
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51637,-0.000562788057947982,0.00263442192898391,-0.00572625503875645,0.00460067892286048,0.830838579119818
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24021.Average evening sound level of noise pollution,51637,-0.000541922417192017,0.00263491244332863,-0.00570635080611614,0.0046225059717321,0.837050566913605
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51637,-0.000573427966341115,0.0026344249070902,-0.00573690078423791,0.00459004485155568,0.82769037868148
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51637,-0.000567959544676789,0.00263470480908619,-0.00573198097048571,0.00459606188113214,0.829326017201266
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51637,-0.000569779790901983,0.00263460261068525,-0.00573360090784507,0.0045940413260411,0.828780948763807
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2405.Number of children fathered,39908,0.0912027431640314,0.0552491879148309,-0.0170856651490371,0.1994911514771,0.0988184024693452
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49378,0.00536522774676454,0.00303173288203183,-0.000576968702017834,0.0113074241955469,0.0767938711557947
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49378,-7.13237511069845e-05,0.00272155564156231,-0.00540557280856911,0.00526292530635514,0.979092508568491
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24502.Water percentage, buffer 1000m",49378,-2.84274113778734e-05,0.00276673104917111,-0.00545122026775326,0.00539436544499751,0.991802198259242
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49378,0.00475839251676811,0.00284229582182019,-0.000812507293999465,0.0103292923275357,0.094119176909778
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49378,-0.000789450701140117,0.0027375764974694,-0.00615510063618014,0.00457619923389991,0.773062082378048
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24505.Water percentage, buffer 300m",49378,-0.000305537667830518,0.00278690459466431,-0.00576787067337257,0.00515679533771153,0.912701255919912
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51782,0.00369266490416434,0.00293818846453556,-0.00206618448632535,0.00945151429465404,0.208845269866165
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51782,0.00357563270163806,0.00274909389714767,-0.00181259133677138,0.00896385674004751,0.193388597864167
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24508.Distance (Euclidean) to coast,51782,-0.00303948370415556,0.00259171759042266,-0.00811925018138396,0.00204028277307285,0.240901182847767
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35416,0.141138872147148,0.065457350336368,0.0128424654878672,0.26943527880643,0.0311065754323485
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2704.Years since last cervical smear test,38265,0.0463189588847214,0.0570956401352282,-0.0655884957803259,0.158226413549769,0.417242187460746
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2714.Age when periods started (menarche),40669,0.0946484784401032,0.0455966703523025,0.00527900454959035,0.184017952330616,0.0379368807338017
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2734.Number of live births,41015,0.0742125400338605,0.0439984923343135,-0.012024504941394,0.160449585009115,0.0916862165486065
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2744.Birth weight of first child,39220,-0.0960713173104038,0.0470706234865549,-0.188329739344051,-0.00381289527675625,0.0412766113811916
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2754.Age at first live birth,38011,-0.00372248722790415,0.00474599859645141,-0.0130246444769489,0.00557967002114061,0.432860382269051
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2764.Age at last live birth,37981,0.00242801032515436,0.00435213513154308,-0.00610217453267006,0.0109581951829788,0.576934079273344
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2794.Age started oral contraceptive pill,36921,0.00844360184862324,0.00674887680275299,-0.00478419668477262,0.0216714003820191,0.210931432150047
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2804.Age when last used oral contraceptive pill,36151,-0.00167954582210732,0.00505834610931623,-0.0115939041963671,0.00823481255215249,0.739873149476128
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2867.Age started smoking in former smokers,36123,-0.00610022646922861,0.00492718544819873,-0.0157575099476981,0.00355705700924089,0.215730091927452
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35953,-0.0838722103164242,0.0750818881840828,-0.231032711157226,0.0632882905243781,0.264001350368048
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35950,-0.0448308857433394,0.0820750592119975,-0.205698001798855,0.116036230312176,0.584934043804797
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35965,0.0588331054913309,0.0857557379552579,-0.109248140900975,0.226914351883636,0.49270227116671
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35941,0.00507528662998663,0.0838694612524595,-0.159308857424834,0.169459430684807,0.951747963275067
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28739.Difficulty with standing for long periods,35971,-0.0921463393294995,0.0631807643456616,-0.215980637446996,0.0316879587879974,0.144761367954864
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28740.Difficulty with taking care of household responsibilities,35993,-0.131249466907288,0.0708886267022124,-0.270191175243624,0.00769224142904834,0.0641426779096618
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28741.Difficulty learning a new task,35934,0.0642937651055922,0.0813164314963791,-0.0950864406273109,0.223673970838495,0.429169426976689
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28742.Difficulty with joining in community activities,35668,-0.0165503752072442,0.0879309417123093,-0.18889502096337,0.155794270548882,0.850709977772096
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35952,-0.0475609827718436,0.0731404042002999,-0.190916175004431,0.0957942094607441,0.515540192309175
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35995,0.0573120429023244,0.112636100833375,-0.16345471473109,0.278078800535739,0.610891538690411
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35654,0.130166576948029,0.0637643890613731,0.00518837438773766,0.25514477950832,0.0412548206641881
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2897.Age stopped smoking,36127,0.0175470955863216,0.00465554007231953,0.00842223704457534,0.0266719541280679,0.000165211546281291
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35260,0.00363498290795878,0.0109997440588773,-0.0179245154474407,0.0251944812633583,0.741063310347827
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35260,-0.00184779782408571,0.0123668942857549,-0.0260869106241653,0.0223913149759939,0.881231250953199
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35260,0.0268800311197233,0.0399611289859983,-0.0514437816928334,0.10520384393228,0.501192776173645
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35260,-0.0507231730216142,0.0474555703815872,-0.143736090969525,0.0422897449262967,0.28517707445031
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35260,0.0295475627155335,0.0577543664516822,-0.0836509955297636,0.142746120960831,0.608944410221808
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35260,0.0222046809553248,0.0485741644339697,-0.0730006813352558,0.117410043245906,0.647594375215943
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35260,-0.0186904618117536,0.0200483464777858,-0.0579852209082139,0.0206042972847066,0.351234372648431
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35260,0.0266710756605792,0.0340392568928873,-0.0400458678494798,0.0933880191706383,0.43334141839829
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35213,-0.0433490092308168,0.0882360628150203,-0.216291692348257,0.129593673886623,0.623243166083624
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29003.Recent feelings of depression,35201,-0.00320572616521872,0.0853537332075129,-0.170499043251944,0.164087590921506,0.970041244343984
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35214,0.0494597100141242,0.0664974546833036,-0.0808753011651507,0.179794721193399,0.457036497710557
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29005.Recent feelings of tiredness or low energy,35217,0.0816956914766678,0.0659509457906116,-0.047568162272931,0.210959545226267,0.215492241617498
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29006.Recent poor appetite or overeating,35229,-0.103157293264076,0.102415885837254,-0.303892429505093,0.0975778429769409,0.313860242760839
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29007.Recent feelings of inadequacy,35195,-0.128780861535617,0.0962117161418238,-0.317355825173592,0.0597941021023579,0.180779215396907
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29008.Recent trouble concentrating on things,35227,-0.0752492316390375,0.0929312674267793,-0.257394515795525,0.10689605251745,0.418127339461634
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35221,0.0602228493604803,0.158010537072248,-0.249477803301126,0.369923502022086,0.703118848500571
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29010.Recent thoughts of suicide or self-harm,35201,0.0474014929590826,0.178929388439113,-0.303300108381579,0.398103094299745,0.791082252725511
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#0.Substances taken for depression_None of options listed,36249,0.00122548511231518,0.02232511821132,-0.0425317465818721,0.0449827168065024,0.956225534257543
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36249,-0.0420917016076382,0.0574158504419648,-0.154626768473889,0.0704433652586128,0.463520292909898
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36249,-0.0499303655231798,0.0229275821243176,-0.0948684264868422,-0.00499230455951733,0.0294582432741716
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36249,-0.0912710919002742,0.0690787637163643,-0.226665468784348,0.0441232849837999,0.186457126663731
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36249,-0.0881449845789997,0.0585885276212108,-0.202978498716573,0.0266885295585733,0.132503828320646
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36249,-0.0718180217725969,0.0598712237115505,-0.189165620247236,0.045529576702042,0.230357713375724
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36249,-0.234603218358886,0.0652022965295707,-0.362399719556845,-0.106806717160928,0.000322768467688584
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36249,-0.0566129424771764,0.0620427366079424,-0.178216706228743,0.0649908212743907,0.361545693369853
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36249,-0.0451370223094843,0.0403316765901238,-0.124187108426127,0.0339130638071585,0.263116088928757
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36249,0.00183279684548823,0.0205318202214491,-0.0384095707885521,0.0420751644795286,0.928872917184524
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36249,0.00207741797063656,0.0362165517761917,-0.0689070235106991,0.0730618594519722,0.954259246187885
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36249,-0.0626526016017375,0.0551551571972248,-0.170756709708298,0.0454515065048231,0.256022900038162
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36249,0.00472534714236951,0.0792662739060908,-0.150636549713569,0.160087243998308,0.95246508293183
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36249,-0.102801521050439,0.0540911618900576,-0.208820198354952,0.00321715625407371,0.0574051837613654
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36249,-0.0547869631483444,0.0749494202430209,-0.201687826824665,0.0921139005279766,0.464812092081926
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36249,-0.0960946839358337,0.0749943468674833,-0.243083603796101,0.0508942359244336,0.200109699358345
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36249,-0.0679797457466898,0.0440355350791431,-0.15428939450181,0.0183299030084308,0.122694373467965
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36249,-0.0582487221552929,0.0409177812505671,-0.138447573406404,0.0219501290958185,0.154619480464969
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36249,-0.0164666117026869,0.0573189778531847,-0.128811808294929,0.0958785848895552,0.77390616212318
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29058.Recent feelings or nervousness or anxiety,35125,-0.140232111180565,0.0788598877837943,-0.294797491236801,0.0143332688756722,0.0754150466081258
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29059.Recent inability to stop or control worrying,35137,0.0162600719398181,0.0806247131150943,-0.141764365765767,0.174284509645403,0.840176908752032
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29060.Recent worrying too much about different things,35135,0.004454634834268,0.0747811076947675,-0.142116336247476,0.151025605916012,0.95250092347548
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29061.Recent trouble relaxing,35131,-0.104276480766495,0.0809367577676351,-0.26291252599106,0.0543595644580694,0.197667461970337
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29062.Recent restlessness,35147,-0.118135934345304,0.11918892453807,-0.351746226439921,0.115474357749313,0.321645135876737
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29063.Recent easy annoyance or irritability,35119,-0.0794276267895555,0.0822455887899302,-0.240628980817819,0.0817737272387077,0.334215115331942
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29064.Recent feelings of foreboding,35119,0.0580768956844639,0.0931641381365994,-0.124524815063271,0.240678606432199,0.533057182127766
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36249,-0.046597792387863,0.0253787933625409,-0.0963402273784431,0.00314464260271706,0.0663861493343279
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36249,-0.018034532359379,0.0454207409003182,-0.107059184524003,0.0709901198052447,0.691338912287488
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36249,-0.0275059727605018,0.0557147815368998,-0.136706944572825,0.0816949990518219,0.621538693536056
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36249,-0.0695288464058611,0.0517471669706036,-0.170953293668244,0.0318956008565219,0.179112523311958
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36249,-0.0594592010938798,0.0397925132026084,-0.137452526970992,0.0185341247832327,0.135160012712008
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36249,-0.0161571236083021,0.0409873560833733,-0.0964923415317138,0.0641780943151097,0.693446960089497
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36249,-0.020760871362912,0.0423029089113909,-0.103674572829238,0.0621528301034142,0.62360652229707
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36249,-0.105926579063406,0.0422920130765191,-0.188818924693384,-0.0230342334334289,0.0122797296145501
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36249,-0.0716740310085342,0.0541747136537456,-0.177856469769876,0.0345084077528072,0.185872824319976
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29076.Felt loved as a child,35117,0.0781520949652443,0.0688245626282173,-0.0567440477860616,0.21304823771655,0.256200874502881
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29077.Physically abused by family as a child,35136,0.0795314653026726,0.102538109656739,-0.121443229624536,0.280506160229882,0.437999336699347
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29078.Felt hated by family member as a child,35124,-0.0637468018127366,0.102036425369366,-0.263738195536695,0.136244591911221,0.532162126847081
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29079.Sexually molested as a child,35078,0.0190640583652967,0.130495178056481,-0.236706490625406,0.274834607356,0.883855239865882
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29080.Someone to take to doctor when needed as a child,35095,0.10137369100738,0.0953214516793234,-0.0854563542840937,0.288203736298854,0.287602003810447
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35129,0.233669748240209,0.150108844908437,-0.0605435877803282,0.527883084260746,0.119602479430155
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35084,-0.0797026697472363,0.112675240302772,-0.300546140740669,0.141140801246196,0.479366853883889
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35133,0.0928447896971593,0.1314422789,-0.164782076946841,0.35047165634116,0.479995684680329
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35122,0.11890675091745,0.181921174615547,-0.237658751329023,0.475472253163923,0.513384020754471
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35121,-0.227801020300333,0.166886942100036,-0.554899426816405,0.0992973862157378,0.17230422116111
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29086.Experienced a violent or sexual assault,35135,-0.209049271863497,0.159397574295677,-0.521468517483024,0.103369973756029,0.189740953065833
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29087.Experienced a life-threatening injury or illness,35129,-0.116121120608286,0.0768007869918857,-0.266650663112382,0.0344084218958102,0.13059264294216
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29088.Experienced a marital separation or divorce,35135,-0.182361383907872,0.077660139889209,-0.334575258090722,-0.0301475097250226,0.0188971078985904
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29089.Experienced the death of a spouse or partner,35142,0.0014547531985815,0.0835674988513551,-0.162337544550074,0.165247050947237,0.98611161384828
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35134,0.0185276318889844,0.0983710101099406,-0.174279547926499,0.211334811704468,0.850613092901078
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29091.Frequency of drinking alcohol,35134,-0.145075184631242,0.0613075518601976,-0.265237986277229,-0.0249123829852548,0.0179963278759547
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34405,-0.141895277523482,0.0768234897208899,-0.292469317376426,0.00867876232946238,0.0647995033642559
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34425,-0.115871397851529,0.0795581575315581,-0.271805386613383,0.0400625909103253,0.145332066532581
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29104.Ever used cannabis,35134,-0.109012202176036,0.11525695859209,-0.334915841016532,0.116891436664461,0.34427948877794
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29108.Ever thought that life not worth living,35101,-0.194485714337477,0.0851168630873369,-0.361314765988657,-0.0276566626862965,0.0223524753063434
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29109.Ever contemplated self-harm,35127,-0.242619768715974,0.127641492847532,-0.492797094697136,0.0075575572651887,0.0573778505324639
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29111.Ever self-harmed,35134,-0.40245243112804,0.225585236897997,-0.844599495448115,0.0396946331920354,0.0744686770400305
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35123,-0.0260671867444743,0.126285755236322,-0.273587267007666,0.221452893518717,0.836474384285659
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36861,-0.131512593220481,0.0599261288884046,-0.248967805841754,-0.0140573805992085,0.0282237352583009
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36861,-0.0955879636727678,0.0440223058769631,-0.181871683191616,-0.00930424415392006,0.0299350686868295
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36861,-0.097934878644539,0.0527257029439055,-0.201277256414594,0.00540749912551575,0.0632867632785805
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36861,-0.146048748608549,0.0779040434503284,-0.298740673771193,0.00664317655409466,0.060868392690281
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35114,-0.0648648322055368,0.0719335233924223,-0.205854538054685,0.076124873643611,0.36723540629801
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X29153.Pain or discomfort today,35125,-0.0140453445713214,0.0647382412171719,-0.140932297356978,0.112841608214335,0.828250164795678
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29154.Anxiety or depression today,35125,0.00617794497725602,0.0846190697105215,-0.159675431655366,0.172031321609878,0.941801500463095
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29166.Frequency of confiding in someone close,34948,0.106079469805723,0.0647897732921375,-0.0209084858468661,0.233067425458313,0.101625184304716
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35108,0.0166459210322638,0.0107225515365702,-0.00437027997941376,0.0376621220439413,0.120614877778413
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35108,-0.0240758486962538,0.0109749204258234,-0.0455866927308678,-0.00256500466163985,0.0282946778593375
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35108,-0.0198939943557608,0.0137051456060599,-0.0467560797436383,0.00696809103211666,0.146673920576304
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35108,-0.00516061856293664,0.0126754994383209,-0.0300045974620456,0.0196833603361723,0.683924784071393
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35108,-0.0139230023529947,0.0218206149156291,-0.0566914075876279,0.0288454028816384,0.523455127928934
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35108,-0.0097988069317464,0.0103681946055787,-0.0301204683586806,0.0105228544951878,0.344654991296797
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35105,-0.00635958903122798,0.0111376962533689,-0.028189473687831,0.015470295625375,0.568023512159551
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35105,-0.0381531094365722,0.017188495123809,-0.0718425598792377,-0.00446365899390663,0.0264777067205427
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35105,-0.00610221230070756,0.0247636059201274,-0.0546388799041572,0.0424344553027421,0.805366790952493
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35105,0.0110058639413682,0.0198544156092318,-0.027908790652726,0.0499205185354625,0.579375174413858
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35105,0.0226315513048825,0.0330435834579615,-0.0421338722727219,0.087396974882487,0.493433861649669
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35105,0.0181179790175648,0.0151161058464792,-0.0115095884415344,0.0477455464766641,0.230736341578651
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29171.Frequency of feeling 'in tune' with people,35006,0.109542673622052,0.0827630572564912,-0.0526729186006708,0.271758265844775,0.185698066956858
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29172.Freuency of feeling that lacks companionship,35087,-0.191235813586534,0.0750227960668235,-0.338280493877508,-0.0441911332955597,0.0108272420545677
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29173.Frequency of feeling left out,35044,-0.0691283329800517,0.0797215128258465,-0.225382498118711,0.0871258321586074,0.385910358590927
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29174.Frequency of feeling isolated from others,35077,-0.204821977225347,0.0825162920981403,-0.366553909737702,-0.0430900447129917,0.0130850778117564
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29175.Tendency to bounce back quickly after hard times,35120,0.082720804051098,0.0656029617403258,-0.0458610009599407,0.211302609062137,0.207383395370018
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29176.Ability to make it through stressful events,35120,-0.0998620011081294,0.0627799445266248,-0.222910692380314,0.0231866901640552,0.111737850941514
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29177.Quick recovery from stressful events,35120,0.104555357937774,0.0647119279805703,-0.0222800209041441,0.231390736779691,0.106211461249328
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29178.Hard to snap back when something bad happens,35120,-0.142764131581043,0.0630752790196873,-0.266391678459631,-0.0191365847024564,0.0236475216326184
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29179.Comes through difficult times with little trouble,35120,0.254822403803503,0.0643561252392223,0.128684398334627,0.380960409272379,7.59656411915033e-05
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29180.Tendency to take a long time to get over setbacks,35120,-0.13378364918625,0.0637273259502795,-0.258689208048797,-0.00887809032370179,0.0358314680875157
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29181.General happiness,35093,-0.106035243415853,0.0660648377914858,-0.235522325487165,0.0234518386554596,0.10854344358861
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29182.Belief that own life is meaningful,35001,0.0246536197792355,0.0665893334117321,-0.105861473707759,0.15516871326623,0.711221828183208
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35473,0.00655951928686503,0.0600393327185332,-0.11111757284146,0.12423661141519,0.913004759414092
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2946.Father's age,30166,0.0235240750894241,0.0241626656623653,-0.023834749608812,0.0708828997876601,0.33051171519266
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2966.Age high blood pressure diagnosed,36675,0.00494432311921392,0.00495377845961411,-0.00476508266162974,0.0146537289000576,0.318267376479301
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51190,0.0254627599202147,0.0028439673627909,0.0198885838891446,0.0310369359512849,3.71914466785465e-19
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51191,0.0410908855678454,0.00298980534874713,0.0352308670843011,0.0469509040513898,8.35485517855256e-43
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30020.Haemoglobin concentration,51191,0.0376604928079693,0.00321314775265422,0.0313627232127671,0.0439582624031716,1.23933490369382e-31
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30030.Haematocrit percentage,51191,0.0361997650988943,0.00312836338647316,0.0300681728614069,0.0423313573363817,7.06370502332374e-31
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30040.Mean corpuscular volume,51191,-0.0161781564644351,0.00274683279099498,-0.0215619487347852,-0.0107943641940849,3.92407782844799e-09
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51191,-0.0140937444531282,0.00276002702441588,-0.0195033974209833,-0.00868409148527305,3.31129067474252e-07
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51191,-0.000667158819518973,0.00270260704934726,-0.0059642686362396,0.00462995099720166,0.805020812317745
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51191,0.00678098271142315,0.00278616064955189,0.00132010783830144,0.0122418575845449,0.0149487841376258
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30080.Platelet count,51191,0.0328486664324256,0.00272212147356732,0.0275133083442336,0.0381840245206175,2.00488227289087e-33
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30090.Platelet crit,51191,0.029981627921833,0.0027730023530683,0.0245465433098191,0.0354167125338469,3.5359720799218e-27
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51191,-0.0137827939595198,0.0026025130737917,-0.0188837195841515,-0.00868186833488803,1.19532951622828e-07
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30110.Platelet distribution width,51191,0.0110780270861622,0.00270274550950415,0.00578064588753404,0.0163754082847903,4.16778050294229e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30120.Lymphocyte count,51152,0.0147394948944376,0.00267932311816845,0.00948802158282746,0.0199909682060478,3.81422418152913e-08
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30130.Monocyte count,51152,0.0191474535895075,0.00274586848984105,0.013765551349419,0.024529355829596,3.18631655971868e-12
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30140.Neutrophill count,51152,0.0183364867458092,0.0028205131784669,0.0128082809160141,0.0238646925756043,8.14390778131912e-11
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30150.Eosinophill count,51152,0.020991233276764,0.00268375209403033,0.0157310791724646,0.0262513873810635,5.44978619801672e-15
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30160.Basophill count,51152,0.0966200119875067,0.0354630793790693,0.0271123764045308,0.166127647570483,0.00644452068296079
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30170.Nucleated red blood cell count,51152,0.407820069878191,0.173997888554719,0.066784208310942,0.748855931445441,0.0190961494103833
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30180.Lymphocyte percentage,51153,-0.00331341800565662,0.0026756279767446,-0.00855764884007604,0.0019308128287628,0.215592056054176
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30190.Monocyte percentage,51153,0.00277578608195533,0.00271649964077883,-0.00254855321397117,0.00810012537788183,0.306875194308772
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30200.Neutrophill percentage,51153,-0.00125974256103001,0.00265693065569743,-0.00646732664619697,0.00394784152413696,0.635408692615676
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30210.Eosinophill percentage,51153,0.013016566379036,0.00266639572785535,0.00779043075243953,0.0182427020056325,1.05908939573522e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30220.Basophill percentage,51153,-0.0017572627632368,0.00266682018391189,-0.00698423032370411,0.00346970479723051,0.509944032044049
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51152,0.407648232927924,0.173986036569966,0.0666356012507899,0.748660864605058,0.0191385699016544
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30240.Reticulocyte percentage,50815,0.0315339098146045,0.0028754139489144,0.0258980984747323,0.0371697211544767,6.54243202183933e-28
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30250.Reticulocyte count,50815,0.0401231515320177,0.00291989254196045,0.0344001621497752,0.0458461409142602,8.68968404671312e-43
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30260.Mean reticulocyte volume,50815,-0.00760417141509757,0.00269135755431806,-0.012879232221561,-0.00232911060863417,0.00472643541701334
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30270.Mean sphered cell volume,50815,-0.0158494749037192,0.00272759789302022,-0.0211955667740388,-0.0105033830333996,6.30548183511583e-09
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50815,0.013356952820529,0.00284078664437784,0.00778901099754842,0.0189248946435095,2.59405227425448e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50815,0.0310728277393042,0.00293045304110246,0.0253291397787434,0.0368165156998651,3.33180497892687e-26
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50815,0.038111954840651,0.00296438803882255,0.0323017542845588,0.0439221553967431,1.08551161626744e-37
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30500.Microalbumin in urine,37005,0.0139787501198996,0.00449935886811694,0.00516000673839043,0.0227974935014088,0.00189782350281804
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51170,0.00830617341622722,0.00297261484992483,0.00247984831037455,0.0141324985220799,0.00520683089946148
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30520.Potassium in urine,51133,0.000327855163750636,0.00279086595167051,-0.00514224210152356,0.00579795242902484,0.906485244356728
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30530.Sodium in urine,51112,0.019422657223358,0.00293346708263912,0.0136730617413853,0.0251722527053306,3.64889863469175e-11
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30600.Albumin,48998,0.00644982834818138,0.0028733732443482,0.000818016789258914,0.0120816399071039,0.0247991195122099
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30610.Alkaline phosphatase,50785,0.0269700873165688,0.002822364695156,0.021438252514063,0.0325019221190746,1.35247893540134e-21
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30620.Alanine aminotransferase,50789,0.0461755142573101,0.00300197876874448,0.0402916358705709,0.0520593926440493,4.15540713871408e-53
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30630.Apolipoprotein A,48854,-0.0148205703791364,0.00315359073200453,-0.0210016082138653,-0.00863953254440752,2.62455320094314e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30640.Apolipoprotein B,50689,0.0413931049045506,0.00261005476762647,0.0362773975600027,0.0465088122490985,2.53881694949015e-56
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30650.Aspartate aminotransferase,50723,0.0340842489480114,0.00287462850518748,0.028449977077844,0.0397185208181789,2.49796764589234e-32
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30660.Direct bilirubin,47620,0.00420698293008884,0.00306915844347133,-0.00180856761911497,0.0102225334792927,0.170476305384657
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30670.Urea,50772,-0.00745122615568131,0.0027808379850412,-0.0129016686063621,-0.00200078370500056,0.00737904530148993
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30680.Calcium,48998,0.0252701408060612,0.00277781137558823,0.0198256305099083,0.0307146511022141,1.01301848615183e-19
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30690.Cholesterol,50792,0.034419279735408,0.00264636106845897,0.0292324120412284,0.0396061474295876,1.57317264501356e-38
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30700.Creatinine,50784,-0.000306144418480121,0.00308683120677242,-0.00635633358375406,0.00574404474679382,0.920998204263657
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30710.C-reactive protein,50730,0.055449362455638,0.00299632366625996,0.0495765680697685,0.0613221568415075,7.18847429884078e-76
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30720.Cystatin C,50798,0.0507230030611831,0.00304229196878634,0.0447601108023619,0.0566858953200044,5.06240796757917e-62
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50786,0.0587653283842495,0.00300070303942954,0.0528839504269676,0.0646467063415314,1.15302787202866e-84
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30740.Glucose,48982,0.00293453175453141,0.00285095421589218,-0.00265333850861726,0.00852240201768008,0.30334395868839
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50741,0.0115167352364083,0.00291538053435172,0.00580258938907897,0.0172308810837377,7.82897215364691e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30760.HDL cholesterol,48988,-0.0337984977909382,0.00322644158874974,-0.0401223233048877,-0.0274746722769887,1.30658103484756e-25
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30770.IGF-1,50666,-0.0293357627461147,0.00275837802094156,-0.0347421836671602,-0.0239293418250693,2.37844120168544e-26
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30780.LDL direct,50743,0.0380500652694462,0.00259042639145468,0.032972829542195,0.0431273009966974,1.30832279206344e-48
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30790.Lipoprotein A,46417,-0.00688491687172098,0.00297476352014616,-0.0127154533712074,-0.00105438037223452,0.0206552064490288
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30810.Phosphate,48960,0.00365999034445462,0.00297845856471921,-0.00217778844239502,0.00949776913130426,0.219153818335339
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30830.SHBG,48826,-0.0102955689953813,0.00345169753711762,-0.0170608961681318,-0.00353024182263073,0.00286017274613711
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30840.Total bilirubin,50703,0.00437220743851854,0.00291828814606651,-0.00134763732777181,0.0100920522048089,0.134093466311867
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30850.Testosterone,48266,0.0116325891500796,0.00464268089180877,0.00253293460213439,0.0207322436980248,0.0122334818090587
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30860.Total protein,48982,0.0288899431489378,0.0027826754933789,0.0234358991819152,0.0343439871159605,3.47261750985559e-25
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30870.Triglycerides,50779,0.0598827556097023,0.00300303916685774,0.0539967988426611,0.0657687123767434,1.11175329174416e-87
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30880.Urate,50758,0.0326760008159575,0.00325270481126165,0.0263006993858847,0.0390513022460304,1.08099560602056e-23
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30890.Vitamin D,49690,-0.0266419171085671,0.00305954121529281,-0.032638617890541,-0.0206452163265932,3.32848679699803e-18
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3137.Number of measurements made,49362,0.0459431525084028,0.0418588575071708,-0.0361002082056519,0.127986513222458,0.27240408530709
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3143.Ankle spacing width,42031,0.00349077676099763,0.00467871405730668,-0.00567950279132347,0.0126610563133187,0.455622194624452
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42030,-0.00785244817241136,0.00364543579054094,-0.0149975023218716,-0.000707394022951117,0.0312548661558396
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3146.Speed of sound through heel,42031,-0.00512991209320223,0.0034918785294551,-0.0119739940109342,0.00171416982452977,0.141830689242858
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42031,-0.00611813603053301,0.00353473656814152,-0.0130462197040904,0.000809947643024371,0.0835006712434116
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3148.Heel bone mineral density (BMD),42019,-0.00709779729966262,0.00354072993592937,-0.0140376279740842,-0.000157966625241063,0.0450252953755447
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X3526.Mother's age at death,47978,-0.000380326243474189,0.00280614314683843,-0.0058803668112775,0.00511971432432913,0.892191576440444
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X3581.Age at menopause (last menstrual period),38313,-0.000285747142322506,0.00386149790634085,-0.00785428303875057,0.00728278875410556,0.941012771138463
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32726,0.0121995846152502,0.00585360106823038,0.000726526521518694,0.0236726427089818,0.0372213000636161
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4100.Ankle spacing width (left),36628,0.00359441999179424,0.00623171987492465,-0.00861975096305808,0.0158085909466466,0.56409594043957
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36625,-0.00411931027432256,0.00483816215854634,-0.0136021081050734,0.00536348755642827,0.394563263380428
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4103.Speed of sound through heel (left),36628,-0.00463234264517657,0.00462062715357296,-0.0136887718661796,0.00442408657582644,0.316117671748241
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36628,-0.00506159063584518,0.00468189315994025,-0.0142381012293281,0.00411491995763771,0.27968808827519
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36623,-0.00530887875636886,0.00468350504195236,-0.0144885486385955,0.00387079112585777,0.257029646861718
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36628,-0.00505570892576836,0.00468188793802733,-0.0142322092843019,0.00412079143276521,0.28024665496051
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4119.Ankle spacing width (right),36629,0.00558571873016931,0.00616165537295055,-0.00649112580081377,0.0176625632611524,0.364685347592281
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36628,-0.00333972123998645,0.00483783199950759,-0.0128218719590213,0.00614242947904844,0.490005550386186
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4122.Speed of sound through heel (right),36629,-0.00174881646659122,0.0046219142084778,-0.0108077683152077,0.00731013538202526,0.705162891748103
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36629,-0.00224727539665587,0.00468300841091107,-0.0114259718820416,0.00693142108872983,0.631327853892549
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36624,-0.00294522432435917,0.00468101395715505,-0.0121200116803831,0.00622956303166474,0.529247213687056
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36629,-0.0022485314567359,0.00468299837067901,-0.0114272082632668,0.00693014534979497,0.631136412807187
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4194.Pulse rate,36969,0.0254667665402095,0.00441563657022899,0.0168121188625606,0.0341214142178583,8.35843310877324e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4195.Pulse wave reflection index,36969,0.000654344884039895,0.00478365650691333,-0.00872162186951023,0.01003031163759,0.89120222838673
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4196.Pulse wave peak to peak time,36963,-0.0159475455861643,0.00435910868453358,-0.0244913986078501,-0.00740369256447853,0.000255433295029104
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4198.Position of the pulse wave peak,36969,0.0219309350214467,0.00465133204457494,0.0128143242140798,0.0310475458288136,2.45944969911179e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4199.Position of pulse wave notch,36969,0.0156911261536036,0.00446809436960918,0.00693366118916963,0.0244485911180376,0.000447581350504567
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36969,0.0209371501571272,0.00458323470953204,0.0119540101264444,0.02992029018781,4.9950348307043e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4269.Number of triplets attempted (left),36788,-0.150754719584062,0.160359073323427,-0.465058503297978,0.163549064129854,0.347192532211597
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4270.Volume level set by participant (left),36697,0.107134257618944,0.0541787282838329,0.00094395018263134,0.213324565055256,0.048030403874605
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4276.Number of triplets attempted (right),36781,-0.116509554335061,0.158755907216382,-0.42767113247917,0.194652023809048,0.463037801752297
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4277.Volume level set by participant (right),36686,0.0617668641146615,0.0543319897959859,-0.0447238358854709,0.168257564114794,0.255640899337857
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4288.Time to answer,36976,0.00119462295128026,0.00520398245161252,-0.00900518265388028,0.0113944285564408,0.818440212091535
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4290.Duration screen displayed,36976,0.00373478912492649,0.00491361563190635,-0.00589589751360995,0.0133654757634629,0.44722393522226
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X46.Hand grip strength (left),51778,-0.0123229049020425,0.00382688202229497,-0.0198235936657407,-0.00482221613834438,0.00128331553299715
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X47.Hand grip strength (right),51803,-0.0119961264443205,0.003794989978099,-0.0194343068013945,-0.00455794608724644,0.00157412741265292
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X48.Waist circumference,51871,0.0633546930800359,0.00579370353018654,0.0519990341608703,0.0747103519992015,9.18872708683628e-28
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X4803.Tinnitus,36875,-0.00816894886963593,0.0613027033280599,-0.128322247392633,0.111984349653362,0.893994470034303
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4825.Noisy workplace,36953,0.143135385229013,0.0703004575054843,0.00534648851826366,0.280924281939762,0.0417790405035538
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4836.Loud music exposure frequency,36911,0.255702079655578,0.115937080548394,0.0284654017807255,0.48293875753043,0.0274466860927952
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X49.Hip circumference,51865,-0.0190806506664971,0.00472891636951402,-0.0283493267507446,-0.00981197458224964,5.48073044093807e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X50.Standing height,51843,-0.00429232716360866,0.00375794695260515,-0.0116579031907147,0.00307324886349743,0.253382953518216
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X5057.Number of older siblings,35762,0.0352862298550269,0.0589045787736244,-0.0801667445412768,0.150739204251331,0.549166523759312
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X51.Seated height,51757,-0.00480906732854576,0.00350881623305242,-0.0116863471453285,0.00206821248823698,0.170523646837523
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5181.Ever had eye surgery,34418,-0.0658135405040831,0.120614294892374,-0.302217558493136,0.17059047748497,0.5853278564575
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),34405,0.00478002647213775,0.00534076968229337,-0.00568788210515726,0.0152479350494328,0.370824661574675
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),34404,0.0112802121844765,0.0054892606632493,0.000521261284507839,0.0220391630844451,0.0399326025578376
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5190.Duration at which refractometer first shown (right),34333,0.00970359930473956,0.00563284264878779,-0.00133677228688451,0.0207439708963636,0.0850061237501605
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5193.Duration at which refractometer first shown (left),34331,0.0101238519630815,0.00568621930686718,-0.00102113787837816,0.0212688418045412,0.0750665279935772
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5199.logMAR, initial (right)",34389,0.0532459963656102,0.0696402022044181,-0.0832487999550492,0.18974079268627,0.444552220979424
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5200.Final number of letters displayed (right),34389,-0.184607288693617,0.396044033498875,-0.960853594351411,0.591639016964177,0.64114329661459
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5201.logMAR, final (right)",34332,-0.000557678891108343,0.00590021949377715,-0.0121221090989115,0.0110067513166949,0.924701108322502
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5202.Number of rounds to result (right),34389,0.12682285951805,0.0644059519547882,0.000587193686665155,0.253058525349435,0.0489928277546307
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5206.logMAR, initial (left)",34385,0.0414872134034895,0.0691910714283823,-0.0941272865961398,0.177101713403119,0.548796642325511
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5207.Final number of letters displayed (left),34385,-0.577365514033439,0.372829682287622,-1.30811169131718,0.1533806632503,0.121537942156577
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5208.logMAR, final (left)",34325,-0.00491513909612707,0.00589608339893092,-0.0164714625580317,0.00664118436577753,0.404529553375283
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5209.Number of rounds to result (left),34383,0.120076545568243,0.0640645127358277,-0.00548989939397929,0.245642990530465,0.0609444244505738
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34136,-0.010666363908537,0.00550164348522302,-0.0214495851395741,0.000116857322500099,0.0525874836415704
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34136,-0.00752153786338302,0.00556059303068846,-0.0184203002035324,0.00337722447676635,0.176229255846205
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5256.Corneal hysteresis (right),34136,0.0106784422947129,0.00555842179573996,-0.00021606442493741,0.0215729490143632,0.0547729750108475
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5257.Corneal resistance factor (right),34136,0.00352021488778589,0.00560884819835671,-0.00747312758099326,0.014513557356565,0.530283117973205
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34130,-0.00361644315180007,0.00540853526390702,-0.0142171722690578,0.00698428596545769,0.503746964854059
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34130,0.00172360348318681,0.00547947248790838,-0.00901616259311361,0.0124633695594872,0.753111734738412
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5264.Corneal hysteresis (left),34130,0.00930575671907467,0.00554935588783374,-0.00157098082107946,0.0201824942592288,0.0936238839790725
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5265.Corneal resistance factor (left),34130,0.0087300978548218,0.00558302615692169,-0.00221263341274472,0.0196728291223883,0.11795551599258
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34525,0.32076056796514,0.366414819924414,-0.397412479086712,1.03893361501699,0.381394210430119
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51811,-0.00927871458279014,0.0141579783842782,-0.0370283522159753,0.018470923050395,0.512236214446123
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51811,-0.004639915209692,0.0150494101761776,-0.0341367591550002,0.0248569287356162,0.75784770145696
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51811,-0.0249215487225519,0.0399154635840156,-0.103155857347223,0.0533127599021187,0.532398639331921
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51811,-0.0281623778280661,0.00609564661849482,-0.0401098452003159,-0.0162149104558162,3.85705552761358e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51811,0.0177701441261647,0.00574085443581035,0.00651806943197638,0.029022218820353,0.00196798835283104
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38133,0.003131515840627,0.0082804768178242,-0.0130982187223084,0.0193612504035624,0.705305402816371
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38133,0.0059380137863494,0.01771949808154,-0.0287922024534691,0.0406682300261679,0.737548577443628
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38133,-0.0330827337044558,0.0217601323675443,-0.0757325931448425,0.00956712573593093,0.128461675520783
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38133,0.0278517172420168,0.0117685014583834,0.00478545438358541,0.0509179801004482,0.0179719432350716
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51878,0.0131964312632285,0.0119255757241106,-0.0101776971560282,0.0365705596824852,0.268493543199289
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51878,0.0131964312632285,0.0119255757241106,-0.0101776971560282,0.0365705596824852,0.268493543199289
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51878,0.0125929121556157,0.0095534801331047,-0.00613190890526947,0.0313177332165009,0.187467018647957
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51878,0.00468259231196256,0.0165688702000582,-0.0277923932801516,0.0371575779040767,0.777475435495731
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51878,0.0429283646819028,0.0393893840050944,-0.0342748279680821,0.120131557331888,0.275792540853815
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51878,0.0247769884275509,0.0270396894339251,-0.0282208028629423,0.0777747797180442,0.359509206093635
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51878,0.0240151022682295,0.0443473520597369,-0.0629057077688549,0.110935912305314,0.588152605032884
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51811,-0.00252140848130844,0.00883147303904698,-0.0198310956378405,0.0147882786752236,0.775261730097628
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51811,0.00349774803287603,0.0149006492078584,-0.0257075244145264,0.0327030204802785,0.814414246121109
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51811,0.0144449616335718,0.00882777477718731,-0.00285747692971531,0.0317474001968589,0.101788982039302
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51811,0.0219209309100491,0.0124785612247664,-0.00253704909049308,0.0463789109105913,0.0789846422666892
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51811,0.0112140929630596,0.0150983221104066,-0.0183786183733373,0.0408068042994566,0.457648217319625
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51811,0.022792077231874,0.00590241451276854,0.0112233447868476,0.0343608096769003,0.000113014180771965
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38717,-0.0308574379721048,0.013458365770333,-0.0572358348819574,-0.00447904106225213,0.0218808025364917
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38717,-0.044780384714127,0.011440298159045,-0.0672033691058551,-0.0223574003223988,9.13109094327221e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38717,-0.0194607386464378,0.0164290971805589,-0.0516617691203333,0.0127402918274577,0.236233367548156
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38717,0.0396770766621512,0.0129016619331503,0.0143898192731766,0.0649643340511258,0.0021085408966023
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51799,0.0422107868383762,0.0202526363039388,0.00251561968265605,0.0819059539940963,0.0371520911817168
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51799,0.0823912970259665,0.0309033567598769,0.0218207177766078,0.142961876275325,0.00767924962926136
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51799,0.0588945577504987,0.0484128732694499,-0.0359946738576231,0.15378378935862,0.223804873972874
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51799,0.0403124776797622,0.0507755514193623,-0.0592076031021878,0.139832558461712,0.427241718463707
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51799,0.0267499805873595,0.0166286162504761,-0.00584210726357354,0.0593420684382926,0.107702161589315
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51799,-0.00839413579717297,0.0232050900440109,-0.0538761122834342,0.0370878406890883,0.717552080238961
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51799,0.0131357425445639,0.0121881739117879,-0.0107530783225404,0.0370245634116681,0.281159105803442
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35896,-0.0167438053333753,0.0160387529545809,-0.0481797611243538,0.0146921504576032,0.296541872623549
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35896,0.0470867839744656,0.0168643633852197,0.0140326317394349,0.0801409362094963,0.00525175063439702
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35896,-0.0390156627081244,0.0234773342558663,-0.0850312378496223,0.00699991243337354,0.0965908624541136
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35896,0.0252143632520519,0.00988453151984958,0.00584068147314676,0.0445880450309571,0.0107668207188491
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40344,-0.0280674805758464,0.00786090956270608,-0.0434748633187504,-0.0126600978329425,0.000357781866484175
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40344,0.0185867076378808,0.00925865723337525,0.000439739460465337,0.0367336758152963,0.0447210723955501
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40344,0.0127116843211666,0.00770087851393009,-0.00238203756613641,0.0278054062084695,0.0988321459157641
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40344,0.00153458988846908,0.0176597348701027,-0.0330784904569323,0.0361476702338705,0.930754408590641
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40344,0.0397807251578753,0.0098859671844702,0.0204042294763137,0.0591572208394368,5.76059370298707e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40344,-0.0289201276802949,0.0142261101025476,-0.0568033034812881,-0.00103695187930157,0.0420872037603553
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51811,-0.048066482853499,0.0164105980196865,-0.0802312549720845,-0.0159017107349136,0.00340404389096532
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51811,-0.0349970457253483,0.0124450259246799,-0.0593892965377209,-0.0106047949129758,0.00492568017872263
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51811,-0.0303341466416698,0.0314624269393315,-0.0920005034427595,0.0313322101594199,0.334986649254945
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51811,-0.0205085802796193,0.0116300982089295,-0.0433035727691211,0.00228641220988262,0.0778456071475634
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51811,-0.0496068573948517,0.0136703482981921,-0.0764007400593082,-0.0228129747303953,0.000285377200060527
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51811,-0.0186594913590603,0.016368730000106,-0.0507422021592679,0.0134232194411474,0.254320283746289
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51811,0.0229458805727539,0.00551562340982011,0.0121352586895065,0.0337565024560013,3.19197359294553e-05
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34806,-0.00843061756224776,0.0141537862661305,-0.0361720386438636,0.0193108035193681,0.551437105793386
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34806,0.0314895825859982,0.0174239188554859,-0.00266129837075418,0.0656404635427506,0.0707749916216899
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34806,-0.0210839134751766,0.0121580821408019,-0.0449137544711483,0.0027459275207951,0.0829467352493433
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34806,0.0152794023136981,0.0114016188358444,-0.00706777060455691,0.0376265752319531,0.180264431254583
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51903,0.0127039920346279,0.00736918795342145,-0.00173961635407808,0.027147600423334,0.0847334084466867
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51903,-0.012194866247949,0.0204743240849823,-0.0523245414545143,0.0279348089586163,0.551436701829964
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51903,0.00510526769136605,0.0061278327895656,-0.00690528457618253,0.0171158199589146,0.404781433162872
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51903,-0.0134743536114763,0.00589134127587318,-0.0250213825121878,-0.00192732471076491,0.0221964975216684
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51903,0.0229285121986597,0.0100530503820473,0.00322453344984693,0.0426324909474725,0.0225723615761259
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51903,-0.0063192267055139,0.00753135003817058,-0.0210806727803282,0.00844221936930043,0.401446548665161
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51903,-0.00652022706638766,0.00616884408112142,-0.0186111614653856,0.00557070733261032,0.290540670492544
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51903,0.0499301646100137,0.0189955926186002,0.0126988030775572,0.0871615261424701,0.00858167602496184
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45343,-0.0184285751629337,0.00644404160094499,-0.0310588967007859,-0.00579825362508154,0.0042447129034985
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45343,0.00164151879931939,0.00669057505814024,-0.0114720083146355,0.0147550459132743,0.806190153703081
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45343,0.00917196003460251,0.00707626984958823,-0.00469752887059043,0.0230414489397954,0.194939761198389
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45343,-0.0203838655705333,0.00971254497289072,-0.0394204537173991,-0.00134727742366749,0.035857504733176
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45343,-0.00350395470009597,0.00645626299159171,-0.0161582301636157,0.00915032076342379,0.587328848939807
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51677,0.00550047715553943,0.00646359369468472,-0.00716816648604263,0.0181691207971215,0.394781946301794
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51677,-0.0152945892292184,0.00525126659722922,-0.0255870717597877,-0.00500210669864912,0.00358840641452923
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51677,-0.00262214485741804,0.00543736513934244,-0.0132793805305292,0.00803509081569314,0.629636254263046
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51677,-0.0463749369534663,0.0117914271447978,-0.0694861341572701,-0.0232637397496626,8.4166102152476e-05
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51696,-0.0301780232961739,0.00584371568208362,-0.0416317060330578,-0.01872434055929,2.43546367866414e-07
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51696,-0.0238910374198593,0.0115923684025319,-0.0466120794888218,-0.00116999535089682,0.0393213677642475
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51811,-0.0312985451247884,0.00532574921031901,-0.0417370135770136,-0.0208600766725631,4.24050870184968e-09
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51811,-0.025884259232641,0.00611256783149002,-0.0378648921823614,-0.0139036262829205,2.29866446430974e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51811,-0.0250025227385645,0.00928324735416986,-0.0431976875527374,-0.00680735792439156,0.00708018165705782
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51811,-0.0288855110275397,0.0126872737229168,-0.0537525675244566,-0.0040184545306227,0.022811585371722
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51811,-0.0165064910639162,0.0160595092348195,-0.0479831291641625,0.0149701470363301,0.304039455294883
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51811,-0.0581420652632227,0.0152788853773899,-0.088088680602907,-0.0281954499235385,0.000141955734148901
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42031,-0.00611871761541702,0.00353471991809019,-0.0130467686548738,0.000809333424039759,0.0834698672179063
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X864.Number of days or week walked 10+ minutes,51325,-0.0672972024204531,0.0323467801744878,-0.130696891562449,-0.00389751327845701,0.0374919490421916
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X874.Duration of walks,48293,3.16241380918553e-05,0.00290532537077378,-0.00566281358862475,0.00572606186480846,0.991315401973985
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50398,-0.0918656682475085,0.0310275284529552,-0.152679624015301,-0.0310517124797164,0.00307201455941025
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X894.Duration of moderate activity,45629,0.00640783888919873,0.0381533866601603,-0.0683727989647154,0.0811884767431129,0.866625142979242
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33389,-0.00152610006695639,0.00686503393610668,-0.0149815665817255,0.0119293664478127,0.824090830960211
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50312,-0.145343286062351,0.0321760117383914,-0.208408269069598,-0.082278303055104,6.30223914260659e-06
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X914.Duration of vigorous activity,40218,-0.00295464148201729,0.00361459039774077,-0.0100392386615892,0.00412995569755463,0.413705641605669
